Return to Web Version
Sigma-Aldrich
Life Science > Cell Biology > Learning Center > Pharmacological Action Table
Cell Biology

Pharmacological Action Table
  Adenosines/P2 Nucleotide Receptors (Purinergics)
Adrenergics
Biogenic Amines
Cholinergics
Dopaminergics
Excitatory Amino Acids
GABAergics
Histaminergics
Imidazoline Binding Site Ligands
Neuropeptides
Pharmacologicals
Serotonergics
Adenosines/P2 Nucleotide Receptors (Purinergics)    
Product Name Product #  Specificity
Adenosine agonists  
Adenosine amine congener solid A-111 A1
2-Chloro-N6-cyclopentyladenosine solid C-142 A1
N6-Cyclohexyladenosine C9901 A1
N6-Cyclopentyladenosine solid C8031 A1
(S)-ENBA E-111 A1
(-)-N6-(2-Phenylisopropyl)adenosine solid P4532 A1
N6-p-Sulfophenyladenosine sodium salt solid S-198 A1
(+)-N6-(2-Phenylisopropyl)adenosine P7665 A1; less active enantiomer
2-Chloroadenosine C5134 A1,A2
N6-Phenyladenosine solid P-108 A1,A2
N6-(2-Phenylethyl)adenosine P-107 A1,A2
Metrifudil M-225 A2
MECA solid A-024 A2,A1
2-Phenylaminoadenosine >97 % solid P-101 A2,A1
HE-NECA solid H8034 A2,A3
CGS-21680 hydrochloride solid C-141 A2A
DPMA solid D-130 A2A
5'-(N-Ethylcarboxamido)adenosine powder E2387 A2B
N6-(4-Aminobenzyl)-N-methylcarboxamidoadenosine solid A-236 A3
N6-2-(4-Aminophenyl)ethyladenosine >95 % A-202 A3
N6-Benzyl-5'-N-ethylcarboxamidoadenosine solid B-152 A3
Chloro-IB-MECA solid C-277 A3
IB-MECA solid I-146 A3
I-AB-MECA solid I-145 A3 probe
Adenosine min. 99 % A9251 Endogenous
Adenosine hemisulfate salt min. 98 % A7636 Endogenous
Adenosine antagonists back to top
CGS-15943 solid C-199 A1
7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine solid C5982 A1
8-Cyclopentyl-1,3-dimethylxanthine crystalline C-102 A1
8-Cyclopentyl-1,3-dipropylxanthine solid C-101 A1
1,3-Dimethyl-8-phenylxanthine crystalline P2278 A1
FSCPX F7927 A1
Xanthine amine congener X-103 A1
1,7-Dimethylxanthine approx. 98 % solid D5385 A1 > A2
1,3-Dipropyl-8-(p-sulfophenyl)xanthine solid A-022 A1 > A2
3-Isobutyl-1-methylxanthine min. 99 % (HPLC) powder I5879 A1 > A2
3-Propylxanthine min. 99 % solid P5679 A1 > A2
8-(p-Sulfophenyl)theophylline solid A-013 A1 > A2
Theophylline anhydrous min. 99 % powder T1633 A1 > A2
3,7-Dimethyl-1-propargylxanthine solid D-134 A2
Aminophylline hydrate min. 98 % powder A1755 A2 > A1
8-(3-Chlorostyryl)caffeine solid C-197 A2A
SCH-58261 99 % (HPLC) solid S4568 A2A
Alloxazine solid A-242 A2B
MRS 1754 >98 % (HPLC) M6316 A2B
MRS 1191 solid M-227 A3
MRS 1220 solid M-228 A3
MRS 1523 >98 % (HPLC) M1809 A3
VUF 5574 V5888 A3
Enzyme inhibitors back to top
erythro-9-(2-Hydroxy-3-nonyl)­adenine hydrochloride solid E-114 Adenosine deaminase
P2 Receptor agonists back to top
Cytidine 5'-triphosphate disodium salt approx. 98 % C1506 Endogenous
Adenosine 5'-[g-thio]triphosphate tetralithium salt min. 75 % powder A1388 P2
Adenosine 5'-triphosphate disodium salt Grade I min. 99 % A2383 P2
2-(Methylthio)adenosine 5'-diphosphate trisodium salt >89 % solid M-152 P2
2-(Methylthio)adenosine 5'-triphosphate tetrasodium salt >91 % solid A-023 P2
Adenosine 5'-[b-thio]diphosphate trilithium salt min. 80 % A8016 P2X
8-Bromoadenosine 5'-triphosphate sodium salt approx. 95 % B3756 P2X
P1,P4-Di(adenosine-5') tetraphosphate ammonium salt approx. 95 % (HPLC) powder D1262 P2X
a,b-Methyleneadenosine 5'-triphosphate lithium salt min. 95 % solid M6517 P2X > P2Y
b,g-Methyleneadenosine 5'-triphosphate disodium salt min. 95 % solid M7510 P2X > P2Y
Adenosine 5'-diphosphate monopotassium salt dihydrate bacterial 98-100 % crystalline A5285 P2X1
Cytidine 5'-triphosphate disodium solution C8552 P2X3
2-Chloroadenosine triphosphate tetrasodium salt solid C-145 P2Y
Uridine 5'-triphosphate trisodium salt solution U1006 P2Y2
Uridine 5'-diphosphate sodium salt from Saccharomyces cerevisiae 95-100 % U4125 P2Y6
P2 Receptor antagonists back to top
P2 Receptor antagonists solid P-178 P2
Suramin sodium salt min. 95 % solid S2671 P2
NF 023 crystalline N8652 P2X1/3
TNP-ATP solid T4193 P2X1/3
Diinosine pentaphosphate pentasodium salt D6938 P2X1
MRS 2159 >98 % (HPLC) solid M7684 P2X1
PPNDS solid P2738 P2X1
Brilliant Blue G min. 90 % (TLC) B5133 P2X7
Adenosine 2',5'-diphosphate sodium salt min. 95 % A5638 P2Y
Adenosine 3',5'-diphosphate sodium salt approx. 97 % A5763 P2Y
Reactive Blue 2 solid R-115 P2Y
MRS 2179 >98 % (HPLC) M3808 P2Y1
MRS 2395 ³98 % (HPLC) solid M5942 P2Y12
Transporter  
Adenosine Transporter Receptor human Membrane suspension A8352  
Transport inhibitors back to top
Dilazep dihydrochloride powder D5294  
Dipyridamole min. 98 % (TLC) powder D9766  
5-Iodotubericidin solid I-100  
S-(4-Nitrobenzyl)-6-thioinosine min. 98 % solid N2255  
Adrenergics   back to top
Product Name Product #  Specificity
Agonists  
6-Fluoronorepinephrine hydrochloride solid B-012 a
Mephentermine hemisulfate salt M3656 a
Metaraminol (+)-bitartrate salt M4773 a
(±)-Octopamine hydrochloride solid O0250 a
(±)-Synephrine min. 99 % S0752 a
Tetrahydrozoline hydrochloride min. 98 % T4264 a
Xylometazoline hydrochloride X6000 a
Dihydroergotamine methanesulfonate salt powder D2763 a (Partial)
(R)-(-)-Phenylephrine hydrochloride P6126 a1
Cirazoline hydrochloride solid C-223 a1A
Methoxamine hydrochloride M6524 a1A, Aa1D
Naphazoline hydrochloride N5504 a1A, Aa1D
Agmatine sulfate salt min. 97 % powder A7127 a2
p-Aminoclonidine hydrochloride solid A0779 a2
B-HT 920 dihydrochloride solid B-162 a2
B-HT 933 dihydrochloride solid B-161 a2
Clonidine hydrochloride solid C7897 a2
Guanabenz acetate salt solid G-110 a2
Guanfacine hydrochloride >98 % (HPLC) G1043 a2
Rilmenidine hemifumarate salt solid R-134 a2
UK 14,304 U-104 a2
Xylazine min. 99 % X1126 a2
Xylazine hydrochloride min. 99 % X1251 a2
Moxonidine hydrochloride min. 98 % M1559 a2A
Oxymetazoline hydrochloride solid O2378 a2A (partial)
Bambuterol hydrochloride >98 % (HPLC) powder B8684 b
(±)-CGP-12177 hydrochloride >98 % solid C-125 b
Isoetharine mesylate salt I3639 b
(±)-Isoproterenol hydrochloride I5627 b
(-)-Isoproterenol (+)-bitartrate salt I2760 b
(-)-Isoproterenol hydrochloride I6504 b
(±)-Isoproterenol hemisulfate salt I5752 b
Tulobuterol hydrochloride T6050 b
R(-)-Denopamine >98 % (HPLC) D7815 b1
Dobutamine hydrochloride min. 98 % D0676 b1
Xamoterol hemifumarate salt >98 % (HPLC) X3253 b1 (Partial)
Clenbuterol hydrochloride min. 95 % C5423 b2
Fenoterol hydrobromide F1016 b2
Formoterol fumarate >98 % (HPLC) F9552 b2
Metaproterenol hemisulfate salt M2398 b2
Procaterol hydrochloride P9180 b2
Ritodrine hydrochloride R0758 b2
Salbutamol S8260 b2
Salbutamol hemisulfate salt S5013 b2
Salmeterol >98 % (HPLC) solid S2692 b2
Terbutaline hemisulfate salt T2528 b2
BRL 37344 sodium salt powder B-169 b3
CL 316,243 min. 98 % C5976 b3
(-)-Epinephrine E4250 Endogenous a, b
(-)-Epinephrine (+)-bitartrate salt solid E4375 Endogenous a, b
(±)-Epinephrine min. 98 % E1635 Endogenous a, b
(±)-Epinephrine hydrochloride E4642 Endogenous a, b
(-)-Norepinephrine (+)-bitartrate salt hydrate min. 99 % solid A9512 Endogenous a, b1
(-)-Norepinephrine min. 98 % crystalline A7257 Endogenous a, b1
(±)-Norepinephrine (+)-bitartrate salt A0937 a, b1
(+)-Isoproterenol (+)-bitartrate salt I8005 Less active enantiomer
Antagonists  
Phenoxybenzamine hydrochloride min. 97 % powder B-019 a
Phentolamine hydrochloride min. 99 % (TLC) powder P7547 a
Phentolamine methanesulfonate salt min. 99 % (TLC) powder P7561 a
Spiroxatrine powder S-103 a
Terazosin hydrochloride min. 98 % (TLC) powder T4680 a
R(+)-Atenolol solid A-142 a1
Benoxathian hydrochloride solid B-016 a1
Doxazosin mesylate >98 % (HPLC) D9815 a1
Fiduxosin hydrochloride >98 % (HPLC) F4303 a1
Moxisylyte hydrochloride >99 % (TLC) powder M5154 a1
Naftopidil dihydrochloride solid N-158 a1
Urapidil hydrochloride solid U-100 a1
Prazosin hydrochloride min. 99 % (TLC) solid P7791 a1 (peripheral)
Prazobind solid P-124 a1 alkylating agent
5-Methylurapidil solid U-101 a1A
(±)-Niguldipine hydrochloride solid N-134 a1A
S(+)-Niguldipine hydrochloride solid N-135 a1A
WB-4101 hydrochloride >99 % (TLC) solid D0411 a1A
L-765,314 min. 98 % L3040 a1B
Spiperone solid S7395 a1B
Chloroethylclonidine dihydrochloride solid B-003 a1B alkylating agent
A-315456 >98 % (HPLC) solid A6351 a1D
BMY 7378 dihydrochloride >98 % solid B-134 a1D
Efaroxan hydrochloride E3263 a2
Idazoxan hydrochloride I6138 a2
MK-912 hydrochloride salt >98 % (HPLC) M7065 a2
Rauwolscine hydrochloride solid R-104 a2
RX 821002 solid R9525 a2
SKF 86466 solid S1563 a2
Tolazoline hydrochloride min. 99 % (titration) powder T6886 a2
Yohimbine hydrochloride min. 98 % (TLC) powder Y3125 a2
BRL 44408 maleate >99 % (HPLC) solid B4559 a2A
Imiloxan hydrochloride >98 % (HPLC) I9531 a2B
Labetalol hydrochloride >99 % (TLC) powder L1011 b
(S)-(-)-Propranolol hydrochloride min. 99 % (TLC) powder P8688 b
(±)-Propranolol hydrochloride min. 99 % (TLC) powder P0884 b
(±)-Sotalol hydrochloride min. 98 % (TLC) powder S0278 b
Atenolol min. 98 % (TLC) powder A7655 b1
S(-)-Atenolol solid A-143 b1
Betaxolol hydrochloride >98 % (HPLC) B5683 b1
CGP-20712A methanesulfonate salt solid C-231 b1
Cyclazosin hydrochloride solid C-247 b1B
(±)-Metoprolol (+)-tartrate salt min. 99 % (titration) powder M5391 b1
Timolol maleate salt min. 98 % (TLC) powder T6394 b1
Alprenolol hydrochloride >99 % (TLC) powder A8676 b1, b2
Pindolol min. 98 % (TLC) powder P0778 b1, b2
S(–)-Pindolol solid P-152 b1, b2
ICI 118,551 hydrochloride min. 99 % (TLC) powder I-127 b2
Bromoacetyl alprenolol menthane powder B-015 b2 > b1 alkylating agent
S(-)-Cyanopindolol hemifumarate salt solid C-238 b3
SR 59230A oxalate salt solid S8688 b3
(R)-(+)-Propranolol hydrochloride min. 99 % (TLC) powder P0689 Less active enantiomer
Enzyme inhibitors  
Benserazide hydrochloride min. 98 % (TLC) solid B7283 L-Amino acid decarboxylase
S-(-)-Carbidopa >98 % solid C-126 L-Amino acid decarboxylase
S(-)-Carbidopa: HBC complex C-164 L-Amino acid decarboxylase
(±)-3-(3,4-Dihydroxyphenyl)-2-methyl-DL-alanine M7277 L-Amino acid decarboxylase
3-Hydroxybenzylhydrazine dihydrochloride 95-98 % (TLC) H9382 L-Amino acid decarboxylase
Ro 41-0960 solid R-108 Catechol-O-methyltransferase
Fusaric acid from Gibberella fujikuroi F6513 Dopamine b-hydroxylase
3-Phenylpropargylamine hydrochloride solid P-106 Dopamine b-hydroxylase
1-Phenyl-3-(2-thiazolyl)-2-thiourea P4015 Dopamine b-hydroxylase
R-(-)-Deprenyl hydrochloride solid M-003 Monoamine oxidase
Hydralazine hydrochloride H1753 Monoamine oxidase
Hydroxylamine hydrochloride min. 99 % (titration) H9876 Monoamine oxidase
Hydroxylamine sulfate salt min. 99 % (titration) H0127 Monoamine oxidase
Iproniazid phosphate salt I7627 Monoamine oxidase
N-Methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine hydrochloride M3778 Monoamine oxidase
Nialamide min. 95 % (HPLC) N1392 Monoamine oxidase
Pargyline hydrochloride P8013 Monoamine oxidase
Phenelzine sulfate salt P6777 Monoamine oxidase
trans-2-Phenylcyclopropylamine hemisulfate salt P1761 Monoamine oxidase
trans-2-Phenylcyclopropylamine hydrochloride P8511 Monoamine oxidase
Quinacrine dihydrochloride min. 90 % Q3251 Monoamine oxidase
Ro 41-1049 hydrochloride solid R-107 Monoamine oxidase
Ro 16-6491 hydrochloride solid R-106 Monoamine oxidase
(±)-2,3-Dichloro-a-methylbenzylamine hydrochloride solid D-103 Phenylethanolamine N-methyltransferase
3-Iodo-L-tyrosine I8250 Tyrosine hydroxylase
a-Methyl-L-tyrosine M8131 Tyrosine hydroxylase
a-Methyl-DL-tyrosine methyl ester hydrochloride min. 98 % (TLC) M3281 Tyrosine hydroxylase
Enzymes  
Catechol-O-methyl Transferase porcine liver Lyophilized powder min. 1,000 units/mg protein C1897  
Phenylethanolamine N-Methyltransferase from bovine adrenal medulla Lyophilized powder P8924  
Metabolites  
DL-4-Hydroxy-3-methoxymandelic acid H0131  
4-Hydroxy-3-methoxyphenylglycol hemipiperazinium salt H1377  
DL-Metanephrine hydrochloride min. 98 % (TLC) powder M8625  
4-Hydroxy-3-methoxyphenylglycol sulfate potassium salt min. 98 % (HPLC) powder H8759  
DL-Normetanephrine hydrochloride min. 98 % N7127  
Neurotoxins  
N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride min. 98 % C8417  
6-Hydroxydopamine hydrobromide H-116  
6-Hydroxydopamine hydrobromide min. 90 % (HPLC) solid H8523  
6-Hydroxydopamine hydrochloride >97 % (titration) crystalline H4381  
6-Hydroxy-DL-DOPA min. 98 % (TLC) powder H2380  
Others  
AH 11110 >98 % (HPLC) solid A3477 a1A ligand
Precursors  
DL-threo-b-(3,4-Dihydroxyphenyl)serine min. 99 % (HPLC) powder D2384  
Dopamine hydrochloride solid H8502  
L-Tyrosine min. 98 % (TLC) T3754  
L-Tyrosine disodium salt min. 98 % (TLC) powder T2269  
L-Tyrosine hydrochloride min. 98 % (TLC) T2006  
Receptors  
b1-Adrenergic Receptor Human recombinant, expressed in Sf 9 cells Membrane suspension B-143  
b1-Adrenergic Receptor Preparation human Lyophilized powder A6728  
b2-Adrenergic Receptor human Membrane suspension recombinant, expressed in Sf 9 cells B-144  
a2A-Adrenergic Receptor human Membrane suspension recombinant, expressed in Sf 9 cells A-213  
a2A-Adrenergic Receptor Preparation human Membrane suspension A6853  
a2C-Adrenergic Receptor human Membrane suspension recombinant, expressed in Sf 9 cells A-214  
Release inhibitors  
Bretylium tosylate >99 % (TLC) powder B8406  
Sympathomimetics  
D-Amphetamine sulfate salt A5880  
DL-Amphetamine sulfate salt A1263  
Benzphetamine hydrochloride B8263  
Cathine hydrochloride from khat shrub (Arabia, Ethiopia) solid C-222  
S(-)-Cathinone hydrochloride C3196  
(+)-Methamphetamine hydrochloride M8750  
(±)-p-Methoxyamphetamine hydrochloride M3404  
2-(Methylamino)propiophenone hydrochloride M5037  
(±)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine hydrochloride solid M-200  
DL-Norephedrine hydrochloride min. 99 % P7876  
Phentermine hydrochloride P8653  
(+)-Pseudoephedrine hydrochloride E2750  
Transport inhibitors  
Reserpine R0875 Vesicular transport inhibitors
Amoxapine A-129  
Cocaine hydrochloride C5776  
Cocaine free base C8912  
Desipramine hydrochloride min. 98 % (TLC) powder D3900  
Maprotiline hydrochloride >99 % (HPLC) powder M9651  
Nisoxetine hydrochloride solid N-151  
Nortriptyline hydrochloride min. 98 % (TLC) powder N7261  
Protriptyline hydrochloride min. 99 % (TLC) powder P8813  
Biogenic Amines   back to top
Product Name Product #  Specificity
Enzyme Inhibitors  
Benserazide hydrochloride min. 98 % (TLC) solid B7283 L-Amino acid decarboxylase
S(-)-Carbidopa: HBC complex C-164 L-Amino acid decarboxylase
(±)-3-(3,4-Dihydroxyphenyl)-2-methyl-DL-alanine M7277 L-Amino acid decarboxylase
3-Hydroxybenzylhydrazine dihydrochloride 95-98 % (TLC) H9382 L-Amino acid decarboxylase
R-(-)-Deprenyl hydrochloride solid M-003 Monoamine oxidase
Hydralazine hydrochloride H1753 Monoamine oxidase
Hydroxylamine hydrochloride min. 99 % (titration) H9876 Monoamine oxidase
Hydroxylamine sulfate salt min. 99 % (titration) H0127 Monoamine oxidase
Iproniazid phosphate salt I7627 Monoamine oxidase
N-Methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine hydrochloride M3778 Monoamine oxidase
Nialamide min. 95 % (HPLC) N1392 Monoamine oxidase
Pargyline hydrochloride P8013 Monoamine oxidase
Phenelzine sulfate salt P6777 Monoamine oxidase
trans-2-Phenylcyclopropylamine hemisulfate salt P1761 Monoamine oxidase
trans-2-Phenylcyclopropylamine hydrochloride P8511 Monoamine oxidase
Quinacrine dihydrochloride min. 90 % Q3251 Monoamine oxidase
Ro 41-1049 hydrochloride solid R-107 Monoamine oxidase
Ro 16-6491 hydrochloride solid R-106 Monoamine oxidase
Nonselective releasers  
D-Amphetamine sulfate salt A5880  
DL-Amphetamine sulfate salt A1263  
S(-)-Cathinone hydrochloride C3196  
(+)-Methamphetamine hydrochloride M8750  
(±)-3,4-Methylenedioxymethamphetamine hydrochloride M6403  
S(+)-3,4-Methylenedioxymethamphetamine hydrochloride solid M-139  
Transport enhancers  
Tianeptine Sodium-Potassium salt solid T1692 Serotonin transport
Transport Inhibitors  
Transport inhibitors >97 % solid F-133 Metabolite
Amitriptyline hydrochloride min. 98 % (TLC) powder A8404 Nonselective
Doxepin hydrochloride approx. 85 % as E-isomer min. 98 % (GC) 15 % as Z-isomer powder D4526 Nonselective
Fluoxetine hydrochloride solid F-132 Nonselective
R-(-)-Fluoxetine hydrochloride >98 % (HPLC) F1678 Nonselective
S-(+)-Fluoxetine hydrochloride >98 % (HPLC) F1553 Nonselective
Imipramine hydrochloride min. 98 % (TLC) crystalline I7379 Nonselective
Indatraline hydrochloride solid I-119 Nonselective
Mazindol min. 99 % (TLC) powder M2017 Nonselective
Mirtazapine ³99 % (HPLC) solid M0443 Nonselective
Nomifensine maleate salt N1530 Nonselective
Trazodone hydrochloride >99 % (HPLC) powder T6154 Nonselective
Trimipramine maleate salt >99 % (TLC) powder T3146 Nonselective
Reboxetine mesylate >96 % (HPLC) solid R6527 Norepinephrine
(R)-Tomoxetine hydrochloride solid T7947 Norepinephrine
Citalopram hydrobromide C7861 Serotonin
Fluvoxamine maleate solid F2802 Serotonin
LY-367,265 L2411 Serotonin
Nefazodone hydrochloride ³99 % (HPLC) solid N5536 Serotonin
Reserpine R0875 Vesicular
Cholinergics   back to top
Product Name Product #  Specificity
Agonists  
Acetylcholine chloride min. 99 % (TLC) solid A6625 Endogenous
(+)-Nicotine (+)-di-p-toluoyltartrate salt min. 99 % (TLC) powder N9765 Less active enantiomer
Arecaidine propargyl ester hydrobromide solid A-140 Muscarinic
Carbamyl-b-methylcholine chloride min. 99 % (TLC) crystalline C5259 Muscarinic
(+)-cis-Dioxolane solid C-008 Muscarinic
(+)-Muscarine chloride approx. 95 % (TLC) powder M6532 Muscarinic
Muscarinic Toxin-1 from Dendroaspis angusticeps venom ³98 % (SDS-PAGE) Lyophilized powder M9308 Muscarinic
Muscarinic Toxin-2 from Dendroaspis angusticeps venom min. 98 % (SDS-PAGE) Lyophilized powder M8058 Muscarinic
Oxotremorine M solid O-100 Muscarinic
Pilocarpine hydrochloride min. 99 % (titration) powder P6503 Muscarinic
Pilocarpine nitrate salt min. 99 % (TLC) powder P6628 Muscarinic
CDD 0097 hydrochloride solid C-258 Muscarinic, M1
McN-A-343 min. 99 % (TLC) powder C7041 Muscarinic, M1
Oxotremorine min. 95 % (TLC) liquid O6876 Muscarinic, M2, M4
Oxotremorine sesquifumarate salt min. 98 % (TLC) powder O9126 Muscarinic, M2, M4
ABT-418 hydrochloride >98 % (HPLC) solid A6476 Nicotinic
Acetylthiocholine chloride min. 99 % (TLC) powder A5626 Nicotinic
Acetylthiocholine iodide min. 98 % (TLC) powder A5751 Nicotinic
(±)-Anabasine min. 90 % (TLC) liquid A5656 Nicotinic
(+)-Anatoxin-A fumarate salt solid A-224 Nicotinic
1,1-Dimethyl-4-phenylpiperazinium iodide min. 99 % (TLC or titration) powder D5891 Nicotinic
(+)-Epibatidine hydrochloride min. 99 % (TLC) powder E1020 Nicotinic
(±)-Epibatidine dihydrochloride min. 99 % (TLC) powder E1145 Nicotinic
Epiboxidine hydrochloride solid E-152 Nicotinic
a-Lobeline hydrochloride approx. 95 % (HPLC) powder L4376 Nicotinic
Methylcarbamylcholine chloride solid M-140 Nicotinic
(-)-Nicotine min. 99 % (GC) liquid N3876 Nicotinic
(-)-Nicotine hemisulfate salt min. 95 % (TLC) approx. 40 % (w/v) in water (nicotine free base content) N1019 Nicotinic
(-)-Nicotine hydrogen tartrate salt min. 98 % (TLC) powder N5260 Nicotinic
(±)-Nicotine min. 99 % (TLC) liquid N0267 Nicotinic
(±)-Nornicotine min. 99 % (TLC) liquid N3018 Nicotinic
RJR-2403 hemigalactarate min. 99 % (HPLC) powder R-130 Nicotinic
RJR-2429 dihydrochloride solid R-131 Nicotinic (neuromuscular)
A-85380 dihydrochloride solid A-251 Nicotinic (neuronal)
DBO-83 solid D7938 Nicotinic (neuronal)
Ivermectin I8898 Nicotinic, a7 modulator
O-Acetyl-L-carnitine hydrochloride min. 99 % (titration) powder A6706 Nonselective
Acetyl-b-methylcholine chloride min. 98 % (TLC) powder A2251 Nonselective
Arecoline hydrobromide min. 99 % (HPLC) powder A6134 Nonselective
Carbamoylcholine chloride min. 98 % (TLC) min. 99 % (titration) crystalline C4382 Nonselective
Antagonists  
Aminobenztropine solid A-138 Muscarinic
Atropine min. 99 % (TLC) powder A0132 Muscarinic
Atropine sulfate salt hydrate min. 97 % (TLC) crystalline A0257 Muscarinic
Atropine methyl bromide min. 99 % (TLC) powder A6883 Muscarinic
Atropine methyl nitrate min. 99 % (TLC) powder A0382 Muscarinic
Benztropine mesylate salt min. 99 % (TLC) powder B8262 Muscarinic
Dicyclomine hydrochloride min. 99 % (TLC) powder D7909 Muscarinic
DL-Homatropine hydrobromide min. 98 % (TLC) powder H0126 Muscarinic
L-Hyoscyamine min. 98 % (TLC) powder H9002 Muscarinic
L-Hyoscyamine hydrobromide min. 99 % (TLC) powder H9253 Muscarinic
Ipratropium bromide min. 99 % (TLC) powder I1637 Muscarinic
Muscarinic Toxin-3 from Dendroaspis angusticeps venom ³98 % (SDS-PAGE) Lyophilized powder M5933 Muscarinic
Orphenadrine hydrochloride O3752 Muscarinic
Oxybutynin chloride min. 99 % (TLC) powder O2881 Muscarinic
Propantheline bromide min. 98 % (TLC) powder P8891 Muscarinic
(±)-Quinuclidinyl benzilate powder C-002 Muscarinic
(-)-Scopolamine hydrobromide trihydrate min. 98 % (TLC) powder S1875 Muscarinic
(-)-Scopolamine hydrochloride min. 90 % (TLC) powder S1013 Muscarinic
(-)-Scopolamine N-butyl bromide min. 99 % (TLC) powder S7882 Muscarinic
(-)-Scopolamine methyl bromide min. 99 % (HPLC) powder S8502 Muscarinic
(-)Scopolamine methyl nitrate S2250 Muscarinic
DL-Trihexyphenidyl hydrochloride solid T1516 Muscarinic
Pirenzepine dihydrochloride min. 98 % (TLC) powder P7412 Muscarinic, M1
Telenzepine dihydrochloride solid T-122 Muscarinic, M1
Gallamine triethiodide min. 98 % (TLC) powder G8134 Muscarinic, M2
Imperialine 97 % solid I7779 Muscarinic, M2
Methoctramine tetrahydrochloride solid M-105 Muscarinic, M2
(+)-Himbacine approx. 98 % (GC) powder H4904 Muscarinic, M2, M4
4-Diphenylacetoxy-N-(2-chloroethyl)piperidine hydrochloride solid D-142 Muscarinic, M3 (Irreversible)
p-Fluorohexahydro-sila-difenidol hydrochloride solid H-127 Muscarinic, M3 > M1 > M2
4-Diphenylacetoxy-N-methylpiperidine methiodide powder D-104 Muscarinic, M3 > M1 = M4 = M5 > M2
Tropicamide solid T9778 Muscarinic, M4
a-Cobratoxin from Naja naja kaouthia C6903 Nicotinic
Condelphine 95 % solid C2108 Nicotinic
a-Conotoxin Im I min. 97 % (HPLC) C2461 Nicotinic
Delcorine min. 97 % (TLC) solid D6939 Nicotinic
Delsoline min. 97 % (TLC) solid D7064 Nicotinic
Deltaline min. 97 % (TLC) solid D7189 Nicotinic
Dihydro-b-erythroidine hydrobromide solid D-149 Nicotinic
Diplacine min. 98 % solid D7564 Nicotinic
Diquine min. 98 % solid D7689 Nicotinic
Fluorocurarine chloride from (From the plant Vinca erecta, from the family Apocynaceae) min. 97 % (TLC) solid F6301 Nicotinic
Hexamethonium bromide H0879 Nicotinic
Hexamethonium chloride solid (hygroscopic) H2138 Nicotinic
Karakoline 97 % solid K4262 Nicotinic
Mecamylamine hydrochloride M9020 Nicotinic
Methyllycaconitine citrate from Delphinium brownii seeds solid M-168 Nicotinic
MG 624 min. 98 % M3184 Nicotinic
Pancuronium bromide P1918 Nicotinic
Pempidine tartrate min. 98 % (TLC) P5114 Nicotinic
Pentolinium di[L(+)-tartrate] P3520 Nicotinic
Quirestine min. 99.5 % (TLC) Q0255 Nicotinic
Temechine hydrobromide min. 99.5 % (TLC) T4569 Nicotinic
Tempidine min. 98 % (TLC) T4694 Nicotinic
Tempidol hydrochloride min. 98 % (TLC) T4944 Nicotinic
Tempoxime hydrochloride min. 98 % (TLC) T4819 Nicotinic
N,N,N-Trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide T6692 Nicotinic
Tetraethylammonium chloride min. 98 % (titration) T2265 Nicotinic
Decamethonium bromide crystalline D1260 Nicotinic (neuromuscular partial agonist)
a-Bungarotoxin from Bungarus multicinctus solid T3019 Nicotinic (neuromuscular)
Succinylcholine chloride dihydrate min. 98 % solid S8251 Nicotinic (neuromuscular)
(+)-Tubocurarine chloride hydrate T2379 Nicotinic (neuromuscular)
RJR-2429 dihydrochloride solid R-131 Nicotinic (neuronal)
Bromoacetylcholine bromide solid B-121 Nicotinic alkylating agent
a-Bungarotoxin–FITC labeled from Bungarus multicinctus T9641 Nicotinic probe
Enzyme inhibitors  
9-Amino-1,2,3,4-tetrahydroacridine hydrochloride A3773 Acetylcholinesterase
1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide A9013 Acetylcholinesterase
Diisopropyl fluorophosphate D0879 Acetylcholinesterase
Edrophonium chloride E3256 Acetylcholinesterase
Eserine E8375 Acetylcholinesterase
Eserine hemisulfate salt E8625 Acetylcholinesterase
  F3918 Acetylcholinesterase
Galanthamine hydrobromide from Lycoris sp. G1660 Acetylcholinesterase
(-)-Huperzine A H5902 Acetylcholinesterase
(±)-Huperzine A H5777 Acetylcholinesterase
Neostigmine bromide min. 98 % (TLC and titration) powder N2001 Acetylcholinesterase
Neostigmine methyl sulfate N2126 Acetylcholinesterase
Pyridostigmine bromide P9797 Acetylcholinesterase
Acetylethylcholine mustard hydrochloride solid C-001 Choline acetyl-transferase
Bromoacetylcholine bromide solid B-121 Choline acetyl-transferase
2-(a-Naphthoyl)ethyl­tri­methyl­ammonium iodide min. 97 % (HPLC) solid N7906 Choline acetyl-transferase
Enzyme substrates  
Acetylthiocholine chloride min. 99 % (TLC) powder A5626 Acetylcholinesterase
Acetylthiocholine iodide min. 98 % (TLC) powder A5751 Acetylcholinesterase
Choline bitartrate approx. 99 % C1629 Choline acetyl-transferase
Choline bromide approx. 99 % C1754 Choline acetyl-transferase
Choline chloride min. 98 % C1879 Choline acetyl-transferase
Enzymes  
Acetylcholinesterase Electrophorus electricus (electric eel) Type III Aqueous solution ³1,000 units/mg protein C2629  
Acetylcholinesterase Electrophorus electricus (electric eel) Type V-S Lyophilized powder ³1,000 units/mg protein C2888  
Acetylcholinesterase bovine erythrocytes Type XII-S Lyophilized powder 0.25-1.0 unit/mg solid C5021  
Acetylcholinesterase human Lyophilized powder Recombinant min. 2,000 units/mg protein (Lowry) C1682  
Choline Acetyltransferase from human placenta suitable for assay of choline Ammonium sulfate suspension min. 20 units/mg protein (biuret) C2898  
Other  
Dithiobiuret 97 % solid D3190 Inhibitor of ACh release
WB64 solid W4761 Muscarinic M2 Ligand
Receptors  
M1 Muscarinic Receptor human recombinant, expressed in CHO cells Membrane suspension M-194  
M2 Muscarinic Receptor human recombinant, expressed in CHO cells Membrane suspension M4560  
M3 Muscarinic Receptor human recombinant, expressed in Sf 9 cells Membrane suspension M-176  
Release enhancers  
Linopirdine solid L-134  
Release inhibitors  
b-Bungarotoxin from Bungarus multicinctus T5644  
Storage inhibitors  
L(–)-Vesamicol hydrochloride solid V-101  
(±)-Vesamicol hydrochloride >98 % solid V-100  
Transport inhibitors  
Acetylethylcholine mustard hydrochloride solid C-001  
Hemicholinium-3 solid H-108  
Dopaminergics   back to top
Product Name Product #  Specificity
Agonists  
A-68930 hydrochoride min. 98 % (HPLC) solid A8852 D1
N-Allyl-(±)-SKF-38393 hydrobromide solid S-168 D1
Chloro-APB hydrobromide solid C-130 D1
(±)-6-Chloro-PB hydrobromide solid S-143 D1
Dihydrexidine hydrochloride solid D5814 D1
Fenoldopam hydrobromide min. 98 % F6800 D1
SKF-75670 hydrobromide >98 % (HPLC) S2941 D1
SKF-83565 hydrobromide >98 % (HPLC) solid S3191 D1
SKF 83959 hydrobromide >98 % (HPLC) solid S2816 D1
SKF-89145 hydrobromide >98 % (HPLC) solid S3316 D1
SKF-89626 hydrobromide >98 % (HPLC) solid S3066 D1
Deoxyepinephrine hydrochloride 95-98 % solid D5886 D1, D2
Pergolide mesylate salt min. 98 % solid P8828 D1, D2
A-77636 hydrochloride min. 97 % solid A-255 D1, D5
R(+)-6-Bromo-APB hydrobromide solid B-135 D1, D5
(R)-(+)-SKF-38393 hydrochloride >96 % solid S-101 D1, D5
(±)-SKF-38393 hydrochloride crystalline D-047 D1, D5
R(+)-SKF-81297 hydrobromide solid S-179 D1, D5
R(+)-SKF-82957 hydrobromide solid S-178 D1, D5
B-HT 920 dihydrochloride solid B-162 D2
R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride solid P-102 D2
(S)-(-)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride >98 % solid P-103 D2
S(-)-Lisuride solid L-122 D2
(±)-2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin hydrochloride solid P-105 D2
R(-)-Propylnorapomorphine hydrochloride solid D-027 D2
Quinelorane dihydrochloride crystalline Q-110 D2
(±)-Quinpirole dihydrochloride solid Q-111 D2
R(+)-Terguride solid T-165 D2
S(-)-Terguride hydrogen maleate solid T-134 D2
R(-)-2,10,11-Trihydroxyaporphine hydrobromide >97 % Small crystals D-029 D2
R(-)-2,10,11-Trihydroxy-N-propyl-noraporphine hydrobromide solid D-030 D2
Dihydroergotamine methanesulfonate salt powder D2763 D2 (partial)
PPHT-fluorescein acetate solid P-138 D2 fluorescent probe
R(-)-N-Allylnorapomorphine hydrobromide solid D-042 D2, D1
  D-004 D2, D1
R-(-)-Apomorphine hydrochloride hemihydrate min. 99 % A4393 D2, D1
2-Bromo-a-ergocryptine methanesulfonate salt solid B2134 D2, D3
(–)-Quinpirole hydrochloride solid Q-102 D2, D3
BP897 >98 % (HPLC) B9308 D3 Partial
FAUC 73 liquid F1041 D3
R(+)-7-Hydroxy-DPAT hydrobromide >98 % solid H-168 D3
cis-8-Hydroxy-3-(n-propyl)-1,2,3a,4,5,9b-hexahydro-1H-benz[e]indole hydrobromide min. 98 % (HPLC) solid P0618 D3
(+)-PD 128,907 hydrochloride >97 % solid P-183 D3
(±)-PD 128,907 hydrochloride solid P-216 D3
Piribedil maleate salt P9233 D3
(±)-7-Hydroxy-2-(di-n-propylamino)tetralin hydrobromide solid H8653 D3 > D2
PD 168,077 maleate salt powder P-233 D4
N-[2-(4-(4-Chlorophenyl)piperazin-1-yl)ethyl]-3-methoxybenzamide solid C7230 D4
Dopamine hydrochloride solid H8502 Endogenous (nonselective)
S(-)-6-Bromo-APB hydrobromide solid B-136 Less active enantiomer
S-(-)-SKF-38393 hydrochloride solid S-102 Less active enantiomer
(±)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide solid D-002 Nonselective
R(-)-Apocodeine hydrochloride solid D-003 Nonselective
(±)-2-Dipropylamino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide solid D-012 Nonselective
Ergocornine >95 % solid E-131 Nonselective
Ergocristine E-140 Nonselective
a-Ergocryptine E5625 Nonselective
m-Tyramine hydrochloride solid D-017 Nonselective
Maleic acid 99 % M-153 Nonselective
R(–)-Norapomorphine hydrobromide solid D-040 Nonselective
Tyramine solid T7255 Nonselective
Tyramine hydrochloride min. 99 % T2879 Nonselective
Antagonists  
LE 300 solid L8401 D1
Droperidol D1414 D1, D2
cis-(Z)-Flupenthixol dihydrochloride F-114 D1, D2
Fluphenazine dihydrochloride F4765 D1, D2
Perphenazine P6402 D1, D2
Thioridazine hydrochloride min. 99 % T9025 D1, D2
cis-Thiothixene T0780 D1, D2
Trifluoperazine dihydrochloride min. 99 % powder T8516 D1, D2
Trifluperidol hydrochloride solid T-103 D1, D2
R(-)-SCH-12679 maleate salt solid S-159 D1, D5
R(+)-SCH-23390 hydrochloride solid D-054 D1, D5
(±)-SKF-83566 hydrochloride solid S-110 D1, D5
Chlorpromazine hydrochloride C8138 D2
Chlorprothixene hydrochloride C1671 D2
S(-)-Eticlopride hydrochloride E-101 D2
(S)-(-)-IBZM oil I-139 D2
L-741,626 solid L-135 D2
N-Methylspiperone hydrochloride solid S-128 D2
Metoclopramide hydrochloride solid M0763 D2
Octoclothepin maleate salt solid O-111 D2
Pimozide P1793 D2
Prochlorperazine dimaleate salt P9178 D2
Promazine hydrochloride P6656 D2
Propionylpromazine hydrochloride P7780 D2
S(-)-Raclopride (+)-tartrate salt >97 % solid R-121 D2
Risperidone solid R-118 D2
Spiperone solid S7395 D2
ST-148 solution S1441 D2
(S)-(-)-Sulpiride S7771 D2
(±)-Sulpiride powder S8010 D2
Triflupromazine hydrochloride T2896 D2
S(+)-Propylnorapomorphine hydrochloride solid D-041 D2 (limbic selective)
S(-)-BZM Semisolid B-146 D2 (precursor to 125I-BZM)
S(+)-O-Desmethylraclopride hydrobromide solid D-204 D2 (precursor to radiolabeled raclopride)
N-(p-Isothiocyanatophenethyl)spiperone hydrochloride N-140 D2 alkylating agent
(+)-Butaclamol hydrochloride solid D-033 D2, D1
Fluspirilene Amorphous solid F-100 D2, D1
Haloperidol powder H1512 D2, D1
Tiapride hydrochloride T0410 D2, D3
Loxapine succinate salt solid L-106 D2, D4
Domperidone solid D-122 D3, D2 (peripheral)
S(-)-DS 121 hydrochloride solid D-206 D3 (autoreceptor)
GR 103691 >98 % (HPLC) solid G0544 D3
GR 218231 >98 % (HPLC) solid G9168 D3
(S)-Nafadotride tartrate >98 % (HPLC) solid N3535 D3
U-99194A maleate salt solid U-116 D3
L-745,870 hydrochloride solid L-131 D4
L-750,667 trihydrochloride solid L-133 D4
RBI 257 maleate salt solid R-123 D4
U-101958 maleate salt solid U-115 D4
Clozapine C6305 D4 > D2, D3
(-)-Butaclamol hydrochloride solid D-034 Less active enantiomer
trans-(E)-Flupenthixol dihydrochloride solid F-115 Less active enantiomer
  S-113 Less active enantiomer
Acetopromazine maleate salt A6908 Nonselective
S(+)-Apomorphine hydrochloride Small crystals D-043 Nonselective
  E1004 Nonselective alkylating agent
Enzyme inhibitors  
Benserazide hydrochloride min. 98 % (TLC) solid B7283 L-Amino acid decarboxylase
S(-)-Carbidopa: HBC complex C-164 L-Amino acid decarboxylase
(±)-3-(3,4-Dihydroxyphenyl)-2-methyl-DL-alanine M7277 L-Amino acid decarboxylase
3-Hydroxybenzylhydrazine dihydrochloride 95-98 % (TLC) H9382 L-Amino acid decarboxylase
3,5-Dinitrocatechol solid D-131 Catechol-O-methyltransferase
Ro 41-0960 solid R-108 Catechol-O-methyltransferase
R-(-)-Deprenyl hydrochloride solid M-003 Monoamine oxidase
Hydralazine hydrochloride H1753 Monoamine oxidase
Hydroxylamine hydrochloride min. 99 % (titration) H9876 Monoamine oxidase
Hydroxylamine sulfate salt min. 99 % (titration) H0127 Monoamine oxidase
Iproniazid phosphate salt I7627 Monoamine oxidase
N-Methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine hydrochloride M3778 Monoamine oxidase
Nialamide min. 95 % (HPLC) N1392 Monoamine oxidase
Pargyline hydrochloride P8013 Monoamine oxidase
Phenelzine sulfate salt P6777 Monoamine oxidase
trans-2-Phenylcyclopropylamine hemisulfate salt P1761 Monoamine oxidase
trans-2-Phenylcyclopropylamine hydrochloride P8511 Monoamine oxidase
Quinacrine dihydrochloride min. 90 % Q3251 Monoamine oxidase
Ro 41-1049 hydrochloride solid R-107 Monoamine oxidase
Ro 16-6491 hydrochloride solid R-106 Monoamine oxidase
Kojic acid K3125 Tyrosinase
3-Iodo-L-tyrosine I8250 Tyrosine hydroxylase
a-Methyl-L-tyrosine M8131 Tyrosine hydroxylase
  M7628 Tyrosine hydroxylase
a-Methyl-DL-tyrosine methyl ester hydrochloride min. 98 % (TLC) M3281 Tyrosine hydroxylase
Enzymes  
Catechol-O-methyl Transferase porcine liver Lyophilized powder min. 1,000 units/mg protein C1897  
L-Phenylalanine decarboxylase Streptococcus faecalis Dried cells min. 5 units/g solid P9957  
Tyrosinase mushroom ³2,000 units/mg solid T7755  
Metabolites  
3,4-Dihydroxyphenylacetic acid D9128  
Homovanillic acid H1252  
3-Hydroxy-4-methoxyphenethylamine hydrochloride H3132  
3-Methoxytyramine hydrochloride min. 96 % M4251  
Neurotoxins  
6-Hydroxydopamine hydrobromide H-116  
6-Hydroxydopamine hydrobromide min. 90 % (HPLC) solid H8523  
6-Hydroxydopamine hydrochloride >97 % (titration) crystalline H4381  
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride solid M-103  
1-Methyl-4-phenyl-2,3-dihydropyridinium perchlorate >98 % solid D-051  
1-Methyl-4-phenylpyridinium iodide solid D-048  
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride M0896  
Others  
N-Methyl-(R)-salsolinol hydrobromide min. 95 % (HPLC) solid M3690 Neurotoxin
Precursors  
3,4-Dihydroxy-D-phenylalanine D9378 Less active enantiomer
D-Tyrosine min. 98 % (TLC) T3254 Less active enantiomer
N-Acetyldopamine monohydrate A8762  
3,4-Dihydroxy-DL-phenylalanine D9503  
  D-009  
L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride solid D1507  
L-Tyrosine min. 98 % (TLC) T3754  
L-Tyrosine disodium salt min. 98 % (TLC) powder T2269  
L-Tyrosine hydrochloride min. 98 % (TLC) T2006  
Receptors  
D1 Dopamine Receptor human recombinant, expressed in Sf9 cells D-178  
D3 Dopamine Receptor rat recombinant, expressed in Escherichia coli Membrane suspension D-181  
D3 Dopamine Receptor human recombinant, expressed in CCLI-3 cells Membrane suspension D-152  
D2long Dopamine Receptor human recombinant, expressed in Sf9 cells Membrane suspension D-180  
D4,2 Dopamine Receptor human recombinant, expressed in CHO cells Non-viable cells D-177  
Releasers  
Amantadine hydrochloride A1260  
Phentermine hydrochloride P8653  
Transport inhibitors  
Amfonelic acid powder D-044  
BTCP hydrochloride solid B-138  
Bupropion hydrochloride solid B-102  
b-CFT Naphthalenesulfonate solid C-124  
4'-Chloro-3a-(diphenylmethoxy)tropane hydrochloride solid C-207  
Cocaine hydrochloride C5776  
Cocaine free base C8912  
4',4''-Difluoro-3a-(diphenylmethoxy)tropane hydrochloride solid D-205  
GBR 12909 dihydrochloride solid D-052  
GBR 12935 dihydrochloride min. 99 % (TLC) powder G9659  
GYKI 52895 solid G-120  
Nomifensine maleate salt N1530  
Reserpine R0875 Vesicular
Transporters  
Dopamine Transporter human recombinant, expressed in CHO cells Membrane suspension D-209  
Excitatory Amino Acids   back to top
Product Name Product #  Specificity
Agonists, Ionotropic  
Aniracetam approx. 98 % A9950 AMPA potentiator
Cyclothiazide C9847 AMPA potentiator
IDRA 21 min. 98 % I5773 AMPA potentiator
L-(+)-2-Amino-6-phosphonohexanoic acid min. 98 % (HPLC) A5352 AMPA/kainate
(S)-5-Fluorowillardiine F2417 AMPA/kainate
(R)-AMPA solid A-266 Less active enantiomer
(S)-AMPA min. 98 % A0326  
(±)-AMPA solid A6816  
(±)-AMPA hydrobromide solid G-017  
2,6-Difluoro-4-[2-(phenylsul­fonyl­amino)­ethyl­thio]­phenoxy­acet­amide >98 % (HPLC) D8941  
Quisqualic acid solid Q2128  
S(-)-Willardiine solid W-105 AMPA/kainate
IEM-1460 solid I0154 Ca2+ permeable APMA receptors
Dihydrokainic acid >99 % solid D1064 Glutamate receptor blocker
ATPO solid A7845 mGluR1-4
ATPA solid A-263  
Domoic acid approx. 90 % solid D6152  
(S)-5-Iodowillardiine solid W-110  
Kainic acid >99 % K0250  
CR 2249 N2034 Glycine potentiator
1-Aminocyclopropanecarboxylic acid ³98 % (TLC) A3903 Glycine site
1-Aminocyclopropanecarboxylic acid hydrochloride 97 % A0430 Glycine site
D-Serine min. 98 % (TLC) S4250 Glycine site
D-Cycloserine synthetic C3909 Glycine site partial agonist
Putrescine dihydrochloride min. 98 % (TLC) P7505 Polyamine site
Spermidine min. 98 % (GC) S2626 Polyamine site
Spermidine trihydrochloride min. 98 % (TLC) S2501 Polyamine site
Spermine approx. 97 % S3256 Polyamine site
Spermine tetrahydrochloride min. 95 % (TLC) S2876 Polyamine site
L-Cysteine hydrochloride monohydrate min. 98 % (TLC) C7880  
Ibotenic acid approx. 95 % solid I2765  
N-Methyl-D-aspartic acid min. 98 % (titration) solid M3262  
cis-2,3-Piperidinedicarboxylic acid P8782  
Quinolinic acid 99 % "P6,320-4"  
Agonists, Metabotropic  
(S)-3,5-Dihydroxyphenylglycine D3689 mGluR1
(+)-3-Hydroxyphenylglycine powder H-173 mGluR1, mGluR5
(±)-3-Hydroxyphenylglycine powder H-174 mGluR1, mGluR5
(2S,1'S,2'S)-2-(Carboxycyclopropyl)glycine solid C-237 mGluR2, mGluR3
N-Acetyl-Asp-Glu min. 97 % (TLC) powder A5930 mGluR3
PBDA >95 % (NMR) liquid P2238 mGluR3
L-(+)-2-Amino-4-phosphonobutyric acid Optical purity: ³95% (HPLC, Marfey's reagent) A7929 mGluR4, mGluR6, mGluR7, mGluR8
O-Phospho-L-serine P0878 mGluR4, mGluR6
trans-(1S,3R)-ACPD >97 % solid A-182 Nonselective
trans-(±)-ACPD solid A-155 Nonselective
Agonists, Nonselective  
D-Aspartic acid min. 99 % (TLC) A8881 Less active enantiomer
D-Glutamic acid min. 99 % (TLC) G1001 Less active enantiomer
L-Aspartic acid min. 98 % (TLC) A9256  
L-Aspartic acid hemimagnesium salt hydrate min. 98 % (TLC) A9506  
L-Aspartic acid potassium salt min. 98 % (TLC) A6558  
L-Aspartic acid sodium salt monohydrate min. 98 % (TLC) A6683  
L-Cysteinesulfinic acid C4418  
Glutamate, Caged solid G3291  
L-Glutamic acid min. 99 % (TLC) G1251  
L-Glutamic acid hydrochloride min. 98 % (TLC) G2128  
L-Glutamic acid potassium salt monohydrate min. 99 % (TLC) powder G1501  
L-Glutamic acid sodium salt hydrate min. 99 % (TLC) powder G1626  
L-Glutamic acid diethyl ester hydrochloride G9378  
L-Homocysteic acid H9633  
D-Homocysteinesulfinic acid min. 98 % (TLC) H3899  
Antagonists, Ionotropic  
GYKI 52466 hydrochloride solid G-119 Allosteric
CX546 solid C-271  
1-Naphthylacetyl spermine trihydrochloride >97 % solid N-193  
CNQX solid C-127  
CNQX disodium salt solid C-239  
CNQX-HBC complex C-169  
DNQX approx. 98 % D0540  
NBQX solid N-171  
NBQX disodium salt solid N-183  
g-D-Glutamylaminomethylsulfonic acid solid G-111  
(2S,4R)-4-Methylglutamic acid solid G-137  
NS 102 solid N-179  
S(+)-Methadone hydrochloride solid M-150 Allosteric
7-Chlorokynurenic acid solid C-121 Glycine site
5,7-Dichlorokynurenic acid solid D-138 Glycine site
6,7-Dichloroquinoxaline-2,3-dione D-133 Glycine site
R(+)-HA-966 solid H-130 Glycine site
Kynurenic acid min. 98 % K3375 Glycine site
L-701,324 L0258 Glycine site
MDL 105,519 solid M-216 Glycine site
(±)-Ketamine hydrochloride solid K2753 Ion channel blocker
(+)-MK-801 hydrogen maleate solid M-107 Ion channel blocker
N-(3,3-Diphenylpropyl)gly­cin­amide >98 % (HPLC) D8816 Ion channel blocker
Phencyclidine hydrochloride P3029 Ion channel blocker
(-)-MK-801 hydrogen maleate solid M-108 Less active enantiomer
Felbamate F0778 NMDAR2B
Ro 25-6981 hydrochloride R7150 NMDAR2B
Ro 8-4304 solid R8900 NMDAR2B
Arcaine sulfate salt A0384 Polyamine site
Ifenprodil tartrate salt I2892 Polyamine site
Philanthotoxin 433 tris(trifluoroacetate) salt >99 % solid P-207 Polyamine site
[Glu3,4,7,10,14]-Conantokin G >90 % (HPLC) C1733 Polyamine-like action
(±)-2-Amino-4-phosphonobutyric acid solid A1910  
D(-)-2-Amino-7-phosphonoheptanoic acid solid A-167  
DL-2-Amino-7-phosphonoheptanoic acid approx. 95 % A5157  
DL-2-Amino-5-phosphonopentanoic acid solid A5282  
D(-)-2-Amino-5-phosphonopentanoic acid solid A-169  
CGS-19755 solid C-105  
CNS-1102 >98 % (HPLC) C4238  
D-CPP solid C-189  
(±)-CPP solid C-104  
d-3-Methoxy-N-methylmorphinan hydrobromide D2531  
Dextrorphan tartrate solid D-127  
Memantine hydrochloride min. 98 % (GC) M9292  
Pentamidine isethionate salt P0547  
Ro 25-6981 hydrochloride R7150  
Ro 8-4304 solid R8900  
Antagonists, Metabotropic  
NPS 2390 min. 99 % (HPLC) solid N4786 mGluR1, mGluR5
AIDA solid A-254 mGluR1
CPCCOEt >98 % (HPLC) solid C9611 mGluR1
(S)-2-Amino-2-methyl-4-phosphonobutyric acid hydrochloride synthetic solid M5560 mGluR4, mGluR6, mGluR7
(±)-a-Methyl-(4-sulfonophenyl)glycine M5046 mGluR4, mGluR7, mGluR8
6-Methyl-2-(phenylethynyl)pyridine solid M5435 mGluR5
SIB 1757 min. 99 % (HPLC) crystalline S9186 mGluR5
SIB 1893 >99 % solid S9311 mGluR5
L-(+)-2-Amino-3-phosphonopropionic acid min. 98 % A3690 Nonselective
DL-2-Amino-3-phosphonopropionic acid A4910 Nonselective
(+)-a-Methyl-4-carboxyphenylglycine solid M-196 Nonselective
(±)-a-Methyl-(4-carboxyphenyl)glycine M4796 Nonselective
Enzyme inhibitors  
L-2-Aminoadipic acid A7275 Glutamine synthetase
DL-2-Aminoadipic acid min. 99 % A0637 Glutamine synthetase
D-2-Aminoadipic acid A7400 Less active enantiomer
Enzymes  
L-Glutamate Oxidase from Streptomyces sp. Lyophilized powder min. 5 units/mg solid G0400  
L-Glutamine Synthetase from sheep brain Lyophilized powder min. 90 units/mg protein G6632  
Metabolites  
L-Glutamine min. 99 % (TLC) G3126  
Others  
NS 521 oxalate solid N7904 Neuroprotectant
Release inhibitors  
Riluzole solid R-116  
Storage inhibitors  
Chicago Sky Blue 6B powder C8679  
Transport inhibitors  
L-2-Aminoadipic acid A7275  
DL-threo-b-Hydroxyaspartic acid H2775  
L-trans-Pyrrolidine-2,4-dicarboxylic acid min. 98 % P7575  
GABAergics   back to top
Product Name Product #  Specificity
Agonists  
g-Aminobutyric acid min. 99 % A2129 Endogenous
3-Amino-1-propanesulfonic acid sodium salt approx. 98 % A4147 GABAA
Chlormethiazole >98 % (HPLC) crystal C1240 GABAA
Etomidate >98 % (HPLC) powder E6530 GABAA
Felbamate F0778 GABAA
Piperidine-4-sulfonic acid P9159 GABAA
THIP hydrochloride solid T-101 GABAA
SB 205384 solid S7936 GABAA a3 b2 γ2
Isoguvacine hydrochloride solid G-002 GABAA GABAC
Muscimol powder M1523 GABAA GABAC
Muscimol hydrobromide powder G-019 GABAA GABAC
3-Aminopropylphosphonic acid A7162 GABAB
R(+)-Baclofen hydrochloride solid G-013 GABAB
SKF 97541 hydrochloride solid A-196 GABAB
S(-)-Baclofen hydrochloride solid G-014 GABAB, less active enantiomer
(E)-4-Amino-2-butenoic acid solid T1694 GABAC
Acenaphthenequinone tech. A-201 GABAC
Antagonists  
(+)-Bicuculline crystalline B9130 GABAA
(-)-Bicuculline methiodide solid B6889 GABAA
1(S),9(R)-(-)-Bicuculline methobromide solid B-103 GABAA
1(S),9(R)-(-)-Bicuculline methochloride B-110 GABAA
tert-Butyl bicyclo[2.2.2]phosphorothionate solid B-104 GABAA
(1S,9R)-(+)-b-Hydrastine H8645 GABAA
SR-95531 solid S-106 GABAA
2-Hydroxysaclofen min. 98 % (TLC) solid A6566 GABAB
Phaclofen solid P-118 GABAB
Saclofen solid S-166 GABAB
4-Imidazoleacetic acid hydrochloride I0375 GABAC
Imidazole-4-acetic acid sodium salt I7013 GABAC
Picrotoxin powder P1675 GABAC
Picrotoxinin P8390 GABAC
SKF 97541 hydrochloride solid A-196 GABAC
(1,2,5,6-Tetrahydropyridin-4-yl)methylphosphinic acid solid T-200 GABAC
Cloflubicyne min. 95 % (NMR) solid C1983 Nonselective
Etbicyphat min. 95 % (NMR) solid E5277 Nonselective
Etbicythionat min. 98 % (NMR) solid E5402 Nonselective
Flucybene min. 95 % (NMR) solid F6551 Nonselective
Propybicyphat 95 % (NMR) solid P5489 Nonselective
Enzyme inhibitors  
3-Amino-2,3-dihydrobenzoic acid hydrochloride min. 98 % A3539 GABA transaminase
4-Amino-5-hexynoic acid solid A-230 GABA transaminase
Vigabatrin V8261 GABA transaminase
S(+)-g-Vigabatrin solid V-113 GABA transaminase
L-Allylglycine min. 99 % (TLC) powder A7762 Glutamic acid decarboxylase
Enzymes  
GABase from Pseudomonas fluorescens Lyophilized powder 0.5-2.0 units/mg protein G7509  
Modulators  
CGP-13501 >98 % (HPLC) C0987 GABAB
Transport inhibitors  
SKF 89976A hydrochloride >98 % (HPLC) S9066 GAT-1
GABAA modulators  
Alprazolam A8800 BDZ site
Carbamazepine powder C4024 BDZ site
Carbamazepine–HBC complex Free flowing powder C-162 BDZ site
Chlordiazepoxide hydrochloride C2517 BDZ site
4'-Chlorodiazepam C5174 BDZ site
Clobazam C8414 BDZ site
Clonazepam powder C1277 BDZ site
Diazepam D0899 BDZ site
Estazolam E3638 BDZ site
Flunitrazepam F9261 BDZ site
Flurazepam dihydrochloride solid F-103 BDZ site
Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys min. 95 % (HPLC) G9898 BDZ site, peripheral
L-655,708 L9787 BDZ site a5 subunit
(±)-Lorazepam L1764 BDZ site
3-Methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine M2922 BDZ site
Midazolam maleate salt M2419 BDZ site
Nitrazepam N3889 BDZ site
Oxazepam O5254 BDZ site
Triazolam T9772 BDZ site
Zolpidem >96 % solid Z-103 BDZ site
Zopiclone Z4900 BDZ site
b-Carboline-3-carboxylic acid N-methylamide E-006 BDZ site
Flumazenil >99 % (HPLC) solid F6300 BDZ site, central
N-Methyl-b-carboline-3-carboxamide:HBC complex Free flowing powder M-156 BDZ site
Methyl b-carboline-3-carboxylate solid E-002 BDZ site
Methyl 6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate solid E-007 BDZ site
PK 11195 C0424 BDZ site, peripheral
Ro 15-4513 solid R-109 BDZ site
3a,21-Dihydroxy-5a-pregnan-20-one min. 95 % P2016 Steroid site
5a-Pregnan-3a-ol-11,20-dione P5052 Steroid site
5a-Pregnan-3a-ol-20-one solid P8887 Steroid site
Dehydroisoandrosterone 3-sulfate sodium salt min. 98 % D5297 Steroid site
Pregnenolone sulfate sodium salt P-162 Steroid site
Oleamide min. 99 % O2136  
Metabolites  
4-Hydroxybutyric acid sodium salt H3635  
Others  
NCS-356 solid N4034 Nonselective
NCS-382 solid N4159 Nonselective
Receptors  
Benzodiazepine Receptor Lyophilized powder E-005  
Transport inhibitors  
Guvacine hydrochloride >96 % solid G-007  
(±)-Nipecotic acid 21,167-2  
NO-711 hydrochloride solid N-142  
Glycinergics   back to top
Product Name Product #  Specificity
Agonists  
b-Alanine A7752  
Glycine min. 99 % (TLC) G7126  
Glycine hydrochloride min. 99 % (TLC) G2879  
Glycine sodium salt min. 99 % (TLC) G6761  
Hypotaurine min. 98 % (TLC) powder H1384  
D-Serine min. 98 % (TLC) S4250  
Taurine min. 99 % T0625  
Antagonists  
Phenylbenzene w-phosphono-a-amino acid solid P-204  
Strychnine S0532  
Strychnine hydrochloride S8753  
Transport inhibitors  
ALX 5407 hydrochloride solid >98 % (HPLC) A8977 GlyT-1
ALX-1393 >98 % (HPLC) powder A5475 GlyT-2
Other  
Tetanus toxin from Clostridium tetani T3194 Glycine release blocker
Tetanus toxin C fragment from Clostridium tetani T3694 Glycine release blocker
Tetanus toxin C-fragment, FITC-labeled Clostridium tetani T3819 Glycine release blocker
Tetanus toxin C fragment, HRP labeled from Clostridium tetani Lyophilized powder T3944 Glycine release blocker
Histaminergics   back to top
Product Name Product #  Specificity
Agonists  
Histamine approx. 97 % H7125 Endogenous
Histamine dihydrochloride min. 99 % (TLC) powder H7250 Endogenous
Histamine diphosphate salt H7375 Endogenous
Dimaprit dihydrochloride solid D-128 H2
Imetit dihydrobromide solid I-135 H3
(R)(-)-a-Methylhistamine dihydrochloride solid H-128 H3
Antagonists  
(+)-Brompheniramine maleate salt B5275 H1
(±)-Brompheniramine maleate salt B2390 H1
S-(+)-Chlorpheniramine maleate salt C4915 H1
(±)-Chlorpheniramine maleate salt min. 99 % (titration with perchloric acid) C3025 H1
Clemastine fumarate salt C8903 H1
Clemizole hydrochloride C5040 H1
Cyproheptadine hydrochloride C6022 H1
Diphenhydramine hydrochloride D3630 H1
Doxylamine succinate salt D3775 H1
Fexofenadine hydrochloride >98 % (HPLC) F9427 H1
Ketotifen fumarate salt K2628 H1
Levocabastine hydrochloride min. 99 % (HPLC) solid L3042 H1
Loratadine >98 % (HPLC) powder L9664 H1
Methapyrilene hydrochloride M9125 H1
Pheniramine maleate salt P6902 H1
Promethazine hydrochloride P4651 H1
Pyrilamine maleate salt P5514 H1
Terfenadine T9652 H1
Triprolidine hydrochloride min. 99 % T6764 H1
Cimetidine C4522 H2
Famotidine F6889 H2
Ranitidine hydrochloride solid R-101 H2
SKF 95282 dimaleate salt >98 % (HPLC) solid S5317 H2
Clobenpropit dihydrobromide solid C-209 H3
3-(1H-Imidazol-4-yl)propyl di(p-fluorophenyl)methyl ether hydrochloride powder I-160 H3
Thioperamide maleate salt solid T-123 H3
Enzyme inhibitors  
S(+)-a-Fluoromethylhistidine hydrochloride solid F-134 Histidine decarboxylase
Metabolites  
1-Methylhistamine dihydrochloride ³98 % (TLC) powder M4910  
Precursors  
D-Histidine monohydrochloride monohydrate min. 98 % (TLC) H7625 Less active enantiomer
L-Histidine min. 99 % (TLC) H8000  
L-Histidine monohydrochloride monohydrate min. 98 % (TLC) H8125  
L-Histidinol dihydrochloride synthetic >98 % (TLC) H6647  
Imidazoline Binding Site Ligands   back to top
Product Name Product #  Specificity
Agmatine sulfate salt min. 97 % powder A7127 Endogenous
AGN 192403 hydrochloride solid A-252 I1
Cirazoline hydrochloride solid C-223 I1
Efaroxan hydrochloride E3263 I1
Harmane H7258 I1
Moxonidine hydrochloride min. 98 % M1559 I1
Naphazoline hydrochloride N5504 I1
Tetrahydrozoline hydrochloride min. 98 % T4264 I1
Antazoline hydrochloride A9899 I2
Benazoline oxalate salt solid B4555 I2
BU99006 >91 % (HPLC) B8433 I2
Clonidine hydrochloride solid C7897 I2
Idazoxan hydrochloride I6138 I2
Amiloride hydrochloride hydrate min. 98 % (TLC) powder A7410 I2 (MAO-A)
Guanabenz acetate salt solid G-110 I2 (MAO-B)
Rilmenidine hemifumarate salt solid R-134 I2 (MAO-B)
BU224 hydrochloride solid B-154 Nonselective
Metrazoline solid M5685  
Neuropeptides   back to top
Product Name Product #  Specificity
b-Amyloid peptides  
Acetyl-Amyloid b-Protein Fragment 15-20 Amide min. 97 % (HPLC) powder A6933  
Amyloid b/A4 Precursor Protein (APP) Fragment 319-335 min. 97 % (HPLC) A1335  
Amyloid BRI Protein Fragment 1-23 min. 84 % (HPLC) solid A3472  
Amyloid BRI Protein Precursor 227 Fragment 89-106 min. 81 % (HPLC) solid A3347  
Amyloid DAN Protein Fragment 1-34 min. 75 % (HPLC) solid A5722  
7-Methoxycoumarin-4-acetyl-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 667-674-(2,4-dinitrophenol)Dap min. 97 % (HPLC) A1222  
Amyloid b/A4 Precursor Protein 770 Fragment 667-676 min. 96 % (HPLC) solid A3222  
7-Methoxycoumarin-4-acetyl-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 667-676-(2,4-dinitrophenyl)Lys-Arg-Arg amide min. 90 % (HPLC) A1472  
Amyloid Precursor Protein C-Terminal Peptide Lyophilized powder A1598  
Amyloid Precursor Protein Frameshift Mutant C-Terminal Peptide Lyophilized powder A1348  
Amyloid Precursor Protein N-Terminal Peptide Lyophilized powder A1473  
Amyloid Protein Non-Ab Component min. 80 % (HPLC) A2835  
Amyloid b Protein Fragment 1-12 min. 90 % (HPLC) Lyophilized powder A7473  
Amyloid b Protein Fragment 1-20 min. 90 % (HPLC) Lyophilized powder A7723  
Amyloid b-protein Fragment 1-28 min. 97 % (HPLC) A0184  
Amyloid b Protein Fragment 1-38 min. 97 % (HPLC) powder A0189  
Amyloid b Protein Fragment 1-40 min. 90 % (HPLC) powder A1075  
Amyloid-b-Protein Fragment 1-40, All D-Amino Acids >70 % (HPLC) Lyophilized powder A5973  
Amyloid b-Protein Fragment 1-40 amide min. 95 % (HPLC) Lyophilized powder A4473  
[Arg13] Amyloid-b-Protein Fragment 1-40 min. 95 % (HPLC) Lyophilized powder A7973  
[Asn(4-aminobutyl)1,7,23,Gln(4-aminobutyl)3,11,22]-Amyloid b-Protein 1-40 min. 90 % (HPLC) A1097  
[Cys]-Amyloid-b-Protein Fragment 1-40 min. 95 % (HPLC) Lyophilized powder A8098  
[Gly5]-Amyloid b-Protein Fragment 1-40 min. 98 % (HPLC) Lyophilized powder A4098  
[Nle35]-Amyloid b-Protein Fragment 1-40 min. 90 % (HPLC) Lyophilized powder A4348  
[Phe10]-Amyloid b-Protein Fragment 1-40 min. 95 % (HPLC) Lyophilized powder A4223  
Amyloid b Protein Fragment 1-42 A9810  
[D-Asp1]-Amyloid b-Protein Fragment 1-42 min. 93 % (HPLC) solid A2472  
Amyloid b-Protein Fragment 1-43 A7712  
[pGlu3]-Amyloid b-Protein Fragment 3-42 min. 90 % (HPLC) solid A2597  
Amyloid b-Protein Fragment 10-20 min. 97 % (HPLC) Lyophilized powder A6825  
Amyloid-b-Protein Fragment 10-35, amide min. 90 % (HPLC) Lyophilized powder A7598  
Amyloid-b-Protein Fragment 13-40 min. 95 % (HPLC) Lyophilized powder A7848  
[Pro18, Asp21]-Amyloid b Protein Fragment 17-21 trifluoroacetate salt min. 98 % (HPLC) solid A3097  
Amyloid b-Protein Fragment 17-28 min. 90 % (HPLC) Lyophilized powder A4723  
Amyloid b-Protein Fragment 17-40 min. 95 % (HPLC) Lyophilized powder A4848  
Amyloid b-Protein Fragment 22-35 min. 95 % (HPLC) A5080  
Amyloid b-Protein Fragment 25-35 min. 97 % (HPLC) A4559  
Amyloid b-Protein Fragment 31-35 min. 95 % (HPLC) A5075  
Amyloid b-Protein Fragment 34-42 min. 90 % (HPLC) Lyophilized powder A4973  
Amyloid b-Protein Fragment 35-42 min. 90 % (HPLC) Lyophilized powder A5098  
Amyloid b-Protein Fragment 40-1 min. 90 % (HPLC) A2326  
Amyloid-b-Protein Fragment 42-1 >95 % (HPLC) Lyophilized powder A6098  
Amyloid b-Protein Fragment 35-25 ³95 % (HPLC) A2201  
Amyloid b/A4 Precursor Protein (APP) Fragment 328-332 98 % (HPLC) Lyophilized powder A8844  
[Asn670, Sta671, Val672]-Amyloid b/A4 Precursor Protein 770 Fragment 662-675 ammonium salt min. 95 % (HPLC) A1847  
DABCYL-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 fragment 661-675-EDANS trifluoroacetate salt min. 97 % (HPLC) solid A4972  
Arg-Glu(EDANS)-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 669-674-(DABCYL)Lys-Arg min. 96 % (HPLC) solid A2847  
7-Methoxycoumarin-4-acetyl-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 669-674-(2,4-dinitrophenyl)Lys trifluoroacetate salt min. 96 % (HPLC) A1597  
[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 667-676 trifluoroacetate salt min. 95 % (HPLC) solid A1972  
DABCYL-[Asn670, Leu671]-Amyloid b/A4 Precursor Protein 770 Fragment 669-674-EDANS ammonium salt min. 95 % (HPLC) solid A5097  
[Val671]-Amyloid b/A4 Precursor Protein 770 Fragment 667-676 trifluoroacetate salt min. 95 % (HPLC) solid A2722  
7-Methoxycoumarin-4-acetyl-[Asn670,Leu671]-Amyloid b/A4 Precursor Protein 770 (667-676)-(2,4-dinitrophenyl)Lys-Arg-Arg Amide min. 96 % (HPLC) A1347  
Angiotensins  
Apelin-13 min. 95 % A6469 APJ
[Asn1, Val5]-Angiotensin II min. 97 % (HPLC) A6402 AT1
[Sar1]-Angiotensin II min. 97 % (HPLC) powder A4410 AT1
[Val5]-Angiotensin II min. 95 % (HPLC) powder A2900 AT1
L-162,313 min. 98 % L1415 AT1
Angiotensin Fragment 1-7 min. 97 % (HPLC) powder A9202 AT2
CGP-42112A >98 % synthetic solid C-160 AT2
Angiotensin I human min. 97 % (HPLC) A9650 Endogenous
Angiotensin II human approx. 95 % (HPLC) powder A9525 Endogenous
[Sar1, Ile8]-Angiotensin II min. 97 % (HPLC) powder A8776 AT1, AT2
[Sar1, Thr8]-Angiotensin II min. 97 % (HPLC) A9900 AT1, AT2
[Sar1, Val5, Ala8]-Angiotensin II min. 97 % (HPLC) powder A2275 AT1, AT2
Angiotensin II antipeptide min. 97 % (HPLC) A4184 AT1, AT2
PD 123,319 di(trifluoroacetate) salt powder P-186 AT2
Angiotensin Converting Enzyme from porcine kidney Lyophilized powder min. 10 units/mg protein (Bradford) A2580  
Angiotensin Converting Enzyme from rabbit lung Lyophilized powder 2-6 units/mg protein (modified Warburg-Christian) A6778  
Angiotensin Converting Enzyme Inhibitor min. 95 % (TLC) A0773  
Captopril C4042  
Angiotensin II Receptor, Type 1 human Membrane suspension A8602  
N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly F7131  
Hippuryl-His-Leu acetate salt H4884  
N-Hippuryl-His-Leu tetrahydrate H1635  
Bombesins  
Bombesin min. 97 % (HPLC) B4272 Endogenous
Gastrin Releasing Peptide human min. 97 % (HPLC) G8022 Endogenous, BB2 > BB1
Gastrin Releasing Peptide porcine min. 97 % (HPLC) G1649 Endogenous, BB2 > BB1
Neuromedin B min. 90 % (HPLC) N3762 Endogenous, BB2 > BB1
Bradykinins  
[Lys-des-Arg9]-Bradykinin min. 95 % (HPLC) B1542 B1
Bradykinin Fragment 1-8 min. 97 % (HPLC) B4397 B1
Bradykinin triacetate salt min. 98 % (HPLC) B3259 Endogenous
Bradykinin Fragment 2-9 min. 97 % (HPLC) B1901 Potentiator
Lys-(des-Arg9, Leu8)-Bradykinin trifluoroacetate salt min. 95 % B6929 B1
[des-Arg10]-HOE 140 synthetic >98 % powder H-158 B1
Na-Adamantaneacetyl-D-Arg-[Hyp3, Thi5,8, D-Phe7]-Bradykinin min. 97 % (HPLC) B6029 B2
Bradyzide di(trifluoroacetate) salt hydrate min. 98 % B1680 B2
HOE 140 min. 94 % solid H-157 B2
Bradykinin Fragment 1-5 min. 97 % (HPLC) B1401  
Cholecystokinins/Gastrins  
Cholecystokinin (CCK) Fragment 26-33 Amide, Non-sulfated min. 95 % (HPLC) powder C2901 CCK Control
[Leu15]-Gastrin I human min. 97 % (HPLC) G9145 CCKB
Mini Gastrin I human min. 97 % (HPLC) G0267 CCKB
Pentagastrin min. 95 % (HPLC) powder B1636 CCKB
Cholecystokinin Fragment 30-33 Amide hydrochloride min. 95 % (HPLC) T6515 CCKB
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide min. 97 % (HPLC) powder C2175 Endogenous
Gastrin I human min. 97 % (HPLC) G9020 Endogenous CCKB
Gastrin I rat min. 97 % (HPLC) G1276 Endogenous CCKB
Big Gastrin I human min. 97 % (HPLC) G5024 Gastrin precursor
Lorglumide sodium salt solid L-109 CCKA
Proglumide sodium salt solid M-006 CCKA > CCKB
CR 2945 I9778 CCKB
Endothelins  
Endothelin 1 human, porcine min. 97 % (HPLC) powder E7764 Endogenous, ETA > ETB
Endothelin 2 min. 97 % (HPLC) powder E9012 Endogenous, ETA, ETB
Endothelin 3 human, rat min. 97 % (HPLC) powder E9137 Endogenous, ETB > ETA
BQ-3020 ³90 % powder E-139 ETB
[Ala1,3,11,15]-Endothelin 1 E6877 ETB
IRL-1620 powder E-137 ETB
Sarafotoxin S6c min. 97 % (HPLC) S6545 ETB
BQ-123 min. 99 % Lyophilized powder B-150 ETA
BQ-610 min. 98 % Lyophilized powder B-151 ETA
Sulfisoxazole min. 99.0 % S6377 ETA
BQ-788 min. 97 % solid B-157 ETB
Kendomycin from Streptomyces violaceoruber solid K1513 Nonselective
PD 142,893 min. 97 % (HPLC) P2959 Nonselective
PD 145,065 min. 97 % (HPLC) P3084 Nonselective
Big Endothelin 38 human ³95 % (HPLC) E9387  
Big Endothelin 39 rat min. 97 % (HPLC) E7265  
Endothelin A Receptor Preparation human Membrane suspension E7155  
Galanins  
Galanin Fragment 1-16, porcine, rat synthetic >98 % powder G-112  
Galanin (2-11) porcine, rat min. 97 % (HPLC) synthetic G8293  
Galanin human min. 97 % (HPLC) powder G0278  
Galanin porcine min. 97 % (HPLC) powder G5773  
Galanin rat min. 97 % (HPLC) powder G8272  
Natriuretic Peptides  
Atrial Natriuretic Peptide rat min. 97 % (HPLC) A8208  
Atrial Natriuretic Peptide human min. 97 % (HPLC) A1663  
Brain Natriuretic Peptide-32 human min. 97 % (HPLC) powder B5900  
Brain Natriuretic Peptide-32 rat min. 97 % (HPLC) powder B9901  
Natriuretic Peptide, C-Type min. 95 % (HPLC) N8768  
Urodilatin human min. 97 % (HPLC) U5754  
Anantin from Streptomyces coerulescens min. 90 % (HPLC) A4316  
Neuropeptide Y and peptide YY  
Neuropeptide Y human min. 95 % (HPLC) powder synthetic N5017 Endogenous Y1, Y2, Y5
Neuropeptide Y porcine min. 97 % (HPLC) synthetic N3266 Endogenous Y1, Y2, Y5
Neuropeptide Y sheep min. 97 % (HPLC) synthetic N6269 Endogenous Y1, Y2, Y5
Neuropeptide Y Fragment 3-36 human, rat min. 97 % (HPLC) N9407 Endogenous Y2, Y5
Peptide YY Fragment 3-36 human ³95 % (HPLC) Lyophilized powder P-220 Endogenous Y2, Y5
Pancreatic Polypeptide human min. 97 % (HPLC) P9903 Endogenous Y4
Pancreatic Polypeptide rat min. 95 % (HPLC) P6410 Endogenous Y4
Peptide YY human min. 97 % (HPLC) synthetic P1306 Endogenous, nonselective
Peptide YY porcine min. 97 % (HPLC) synthetic P5801 Endogenous, nonselective
N-Acetyl-[Leu28, Leu31]-Neuropeptide Y Fragment 24-36 min. 98 % (HPLC) powder N9398 Y Y2
[Leu31, Pro34]-Neuropeptide Y human min. 97 % (HPLC) N6146 Y1, Y5
[Leu31, Pro34]-Neuropeptide Y porcine min. 97 % (HPLC) N7768 Y1, Y5
[Pro34]-Peptide YY min. 95 % P3982 Y1, Y5
Galanin (1-13)-Neuropeptide Y (25-36) Amide min. 95 % G8165 Y2
Glucagon-Like Peptide 2 -Arg human trifluoroacetate salt >90 % (HPLC) solid G8166 Y2
Neuropeptide Y Fragment 13-36 porcine min. 97 % (HPLC) N6521 Y2
[Ala31, a-Aminoisobutyryl32]-Neuropeptide Y porcine >98 % (HPLC) solid N8154 Y5
Neuropeptide Y Fragment 19-23-[Gly1, Ser3, Gln4, Thr6, Ala31, a-Aminoisobutyryl-a-methyl-Ala32, Gln34]-Pancreatic Polypeptide human >97 % (HPLC) solid N8404 Y5
[CPP1-7, NPY19-23, Ala31, Aib32, Gln34]-Pancreatic polypeptide P4118 Y5
BIBP 3226 B-174 Y1
CGP 71683A >98 % (HPLC) solid C4363 Y5
Neurotensins  
Neurotensin approx. 95 % (HPLC) N6383 Endogenous
Obesity research  
Exendin-3 min. 97 % E7019 GLP-1
Exendin-4 min. 97 % E7144 GLP-1
Leptin from mouse ³97 % (SDS-PAGE) recombinant, expressed in Escherichia coli Lyophilized powder L3772 Leptin (OB)
Leptin from rat ³97 % (SDS-PAGE) recombinant, expressed in Escherichia coli Lyophilized powder L5037 Leptin (OB)
Leptin human ³97 % (HPLC) recombinant, expressed in Escherichia coli Lyophilized powder L4146 Leptin (OB)
Peptide YY human min. 97 % (HPLC) synthetic P1306 Nonselective NPY
Peptide YY porcine min. 97 % (HPLC) synthetic P5801 Nonselective NPY
Orexin A human, rat, mouse min. 97 % (HPLC) O6012 OX1
Orexin B human min. 97 % (HPLC) O6137 OX2
Orexin B rat, mouse min. 97 % (HPLC) O6262 OX2
Melanin Concentrating Hormone rat min. 90 % (HPLC) M4542 SLC-1
Neuropeptide Y human min. 95 % (HPLC) powder synthetic N5017 Y1, Y2, Y5
Neuropeptide Y porcine min. 97 % (HPLC) synthetic N3266 Y1, Y2, Y5
Neuropeptide Y sheep min. 97 % (HPLC) synthetic N6269 Y1, Y2, Y5
CART Fragment 55-102 human >95 % C5977  
CART Fragment 55-102 rat >95 % C6102  
CART Fragment 61-102 rat min. 95 % C6227  
Exendin Fragment 9-39 min. 90 % E7269 GLP-1
[Acetyl-Cys3, Nle4, Arg5, D-2-Nal7, Cys11]-a-Melanocyte Stimulating Hormone Fragment 3-11 amide min. 95 % M4558 MC4
Acetyl-[Nle4, Asp5, D-2-Nal7, Lys10]-cyclo-a-Melanocyte Stimulating Hormone Amide Fragment 4-10 min. 95 % (HPLC) M4603 MC4 > MC3
Neuropeptide Y Subtype 2 Receptor human Membrane suspension N4036 Y2
Opioids  
[D-Ala2, D-Leu5]-Enkephalin acetate salt min. 97 % (HPLC) E7131 γ
[D-Pen2,5]-Enkephalin approx. 95 % (HPLC) E3888 γ
[D-Pen2,5, p-Cl-Phe4]-Enkephalin min. 97 % (HPLC) E6264 γ
[D-Pen2, Pen5]-Enkephalin min. 97 % (HPLC) E2260 γ
[D-Ala2]-Deltorphin II min. 97 % (HPLC) T0675 γ2
[D-Ser2]-Leucine Enkephalin-Thr acetate salt >97 % solid D-191 γ2, µ1
b-Funaltrexamine hydrochloride solid O-003 κ
GR-89696 fumarate salt solid G-133 κ
Naloxone benzoylhydrazone solid N-165 κ
(-)-trans-(1S,2S)-U-50488 hydrochloride solid U-111 κ
(±)-trans-U-50488 methanesulfonate salt D8040 κ
U-62066 solid U-105 κ
U-69593 solid U-103 κ
ICI 204,448 hydrochloride solid I-122 κ (peripheral)
b-Casomorphin bovine min. 97 % (HPLC) C5900 µ
b-Casomorphin human min. 97 % (HPLC) C0783 µ
Codeine sulfate salt C-122 µ
DALDA >96 % solid D-144 µ
[D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin acetate salt min. 97 % (HPLC) E7384 µ
Fentanyl citrate salt F3886 µ
Hydrocodone (+)-bitartrate salt H4516 µ
Hydromorphone hydrochloride H5136 µ
Levorphanol tartrate salt L5143 µ
Meperidine hydrochloride M3142 µ
(±)-Methadone hydrochloride M0267 µ
Morphine 6-b-D-glucuronide hydrate min. 90 % (HPLC) M3528 µ
Morphine sulfate salt pentahydrate M8777 µ > κ
Loperamide hydrochloride L4762 µ (peripheral)
Nalbuphine hydrochloride dihydrate min. 98 % (HPLC) N4396 µ partial agonist
Butorphanol tartrate salt min. 99 % B9156 "µ, κ"
a-Endorphin human min. 97 % (HPLC) E6136 Endogenous
[Met5]Enkephalin acetate salt hydrate min. 97 % (HPLC) M6638 Endogenous γ, µ
Leucine Enkephalin min. 95 % (HPLC) L9133 Endogenous γ, µ
Dynorphin A Porcine Fragment 1-8 min. 97 % (HPLC) D4899 Endogenous κ
Dynorphin A Porcine Fragment 1-13 min. 97 % (HPLC) D7017 Endogenous κ
Dynorphin A porcine min. 95 % (HPLC) D8147 Endogenous κ
Dynorphin B porcine min. 95 % (HPLC) D1398 Endogenous κ
Endomorphin 1 E3273 Endogenous µ
Endomorphin 2 E3148 Endogenous µ
b-Endorphin bovine, camel, ovine min. 97 % (HPLC) E0637 Endogenous µ, γ, ε
b-Endorphin human min. 95 % (HPLC) E6261 Endogenous µ, γ, ε
b-Endorphin rat min. 97 % (HPLC) E1142 Endogenous µ, γ, ε
Methionine Enkephalin-Arg-Phe min. 97 % (HPLC) E5757 Endogenous nonselective, σ
S(+)-Methadone hydrochloride solid M-150 less potent enantiomer
(+)-trans-(1R,2R)-U-50488 hydrochloride solid U-110 less potent enantiomer
Buprenorphine hydrochloride B9275 ORL1
Orphanin FQ min. 95 % (HPLC) O4011 ORL1
ICI 174,864 solid I-128 γ
Naltrindole hydrochloride solid N-115 γ
Naltriben methanesulfonate salt solid N-156 γ2
Naltrindole isothiocyanate hydrochloride solid N-157 γ2
CTAP min. 95 % C6352 µ
Cyprodime hydrobromide >96 % solid C-153 µ
3-Methoxynaltrexone hydrochloride solid M-231 µ
b-Funaltrexamine hydrochloride solid O-003 µ alkylating agent
Naloxonazine dihydrochloride solid N-176 µ1
[N-Phe1]-Nociceptin Fragment 1-13 amide synthetic Lyophilized powder N0524 Nociceptin
Buprenorphine hydrochloride B9275 Nonselective
Nalmefene N5770 Nonselective
Naloxone hydrochloride dihydrate min. 98 % (TLC and titration) powder N7758 Nonselective
Naltrexone hydrochloride N3136 Nonselective
b-Chlornaltrexamine dihydrochloride solid O-001 Nonselective (irreversible)
Naloxone methiodide solid N-129 Nonselective (peripheral)
Levallorphan tartrate salt solid L-121 Nonselective partial agonist
Nalorphine hydrochloride solid N-100 Nonselective partial agonist
[Phe1-y(CH2-NH)-Gly2]-Nociceptin Fragment 1-13 amide Lyophilized powder N-213 ORL1
Nocistatin >98 % Lyophilized powder N-215  
Proctolin acetate salt min. 97 % (HPLC) P4280 Aminoenkephalinase
des-Tyr1-Leucine enkephalin acetate salt min. 97 % (HPLC) E7255 Enkephalinase
DL-Thiorphan min. 97 % (TLC) T6031 Enkephalinase
Tyr-Gly-Gly min. 97 % (HPLC) T9005 Enkephalin
Thebaine powder T2019 Morphine
Morphine 3-b-D-glucuronide M6886 Morphine
Releasing Factors  
Corticotropin Releasing Factor bovine min. 90 % (HPLC) C2671 Agonist
Corticotropin Releasing Factor human, rat min. 95 % (HPLC) C3042 Agonist
Corticotropin Releasing Factor sheep min. 95 % (HPLC) C3167 Agonist
Sauvagine min. 97 % (HPLC) S3884 Agonist
Urocortin human min. 85 % (HPLC) powder U4127 Agonist
Urocortin rat min. 97 % (HPLC) powder U6631 Agonist
Urotensin II human min. 97 % (HPLC) synthetic U7257 Agonist
Urotensin II mouse min. 97 % (HPLC) synthetic U7382 Agonist
Urotensin II rat min. 97 % (HPLC) synthetic U7507 Agonist
Urotensin I teleost fish min. 95 % (HPLC) U7253 Agonist
Antalarmin hydrochloride >98 % (HPLC) solid A8727 Antagonist, CRF1
Astressin min. 90 % (HPLC) A4933 Antagonist, CRF2
Astressin2B trifluoroacetate salt min. 98 % A5227 Antagonist, CRF2
Corticotropin Releasing Factor Antagonist min. 97 % (HPLC) C2917 Antagonist
NBI 27914 >98 % (HPLC) N3911 Antagonist, CRF1
Corticotropin Releasing Factor Fragment 6-33 min. 97 % (HPLC) C0961 Binding protein inhibitor
Ghrelin human Lyophilized powder G3902 Agonist
Ghrelin rat Lyophilized powder G8903 Agonist
Growth Hormone Releasing Factor bovine min. 97 % (HPLC) powder synthetic G0644 Agonist
Growth Hormone Releasing Factor human min. 95 % (HPLC) powder synthetic G8895 Agonist
Growth Hormone Releasing Factor Fragment 1-29 amide human min. 97 % (HPLC) G6771 Agonist
Growth Hormone Releasing Factor porcine min. 97 % (HPLC) powder synthetic G0769 Agonist
Growth Hormone Releasing Factor rat min. 95 % (HPLC) powder synthetic G6646 Agonist
Pituitary adenylate cyclase activating polypeptide-38 A1439 Agonist
Pituitary adenylate cyclase activating polypeptide-27 ovine min. 97 % (HPLC) solid A9808 Agonist
[D-Lys3]-GHRP-6 synthetic Lyophilized powder G4535 Antagonist
Pituitary adenylate cyclase activating polypeptide amide fragment 6-27 A6938 Antagonist
Buserelin min. 90 % (HPLC) B3303 Agonist
Leuprolide acetate salt min. 98 % (HPLC) L0399 Agonist
[D-Ala6]-LH-RH min. 97 % (HPLC) L1898 Agonist
[D-Lys6]-LH-RH min. 95 % (HPLC) powder L5022 Agonist
[D-Ser4]-LH-RH >97 % (HPLC) L4663 Agonist
[His(3-Methyl)2]-LH-RH >96 % (HPLC) L4913 Agonist
[des-Gly10, D-Ala6]-LH-RH ethylamide min. 98 % (HPLC) powder L4513 Agonist
[des-Gly10, D-His(Bzl)6]-LH-RH ethylamide min. 97 % (HPLC) powder L2761 Agonist
[des-Gly10, D-Trp6]-LH-RH ethylamide min. 97 % (HPLC) L5386 Agonist
LH-RH Fragment 1-2 >97 % (HPLC) L5913 Agonist
LH-RH Fragment 1-4 >98 % (HPLC) L6038 Agonist
[D-Trp6]-LHRH Fragment, 1-6 >96 % (HPLC) L5038 Agonist
[D-His(Bzl)6]-LH-RH Fragment 1-7 >96 % (HPLC) L4538 Agonist
[D-His(Bzl)6]-LH-RH Fragment 2-9 >99 % (HPLC) L4413 Agonist
Formyl-[D-Trp6]-LH-RH Fragment 2-10 >97 % (HPLC) L5413 Agonist
[D-His(benzyl)6]-LH-RH Fragment 3-9 ethylamide trifluoroacetate salt >99 % (HPLC) L3538 Agonist
LH-RH Fragment 1-6 amide >97 % (HPLC) White powder L6163 Agonist
[D-His(Bzl)6]-LH-RH Fragment 4-9 ethylamide trifluoroacetate salt >95 % (HPLC) L3413 Agonist
[D-His(Bzl)6]-LH-RH Fragment 5-9 Ethylamide trifluoroacetate salt >98 % (HPLC) L3288 Agonist
[D-Trp6]-LH-RH-Leu-Arg-Pro-Gly-NH2 >96 % (HPLC) L4788 Agonist
[D-Trp6]-LH-RH min. 97 % (HPLC) powder L9761 Agonist
Luteinizing Hormone-Releasing Hormone human acetate salt min. 98 % (HPLC) powder L7134 Agonist
Luteinizing Hormone-Releasing Hormone salmon min. 98 % (HPLC) L4897 Agonist
Antide min. 97 % (HPLC) A8802 Antagonist
SDZ-216,887 S3311 Antagonist
LH-RH Antagonist >97 % (HPLC) L5788 Antagonist
Motilin porcine min. 97 % (HPLC) M4505 Cofactor
Prolactin-releasing Peptide Fragment 12-31 human min. 97 % (HPLC) P7107 Agonist
Prolactin-releasing Peptide Fragment 12-31 rat min. 97 % (HPLC) P7357 Agonist
Prolactin-releasing Peptide human min. 97 % (HPLC) P6982 Agonist
Prolactin-releasing Peptide rat min. 97 % (HPLC) P7232 Agonist
pGlu-3-Methyl-His-Pro Amide min. 97 % (HPLC) P5173 Agonist
pGlu-Glu-Pro Amide min. 97 % (HPLC) P2053 Analog
Thyrotropin releasing hormone acetate min. 97 % (HPLC) P2161 Endogenous
Thyrotropin releasing hormone acetate cell culture tested powder T9146 Endogenous
Thyrotropin releasing hormone min. 98 % (HPLC) powder P1319 Endogenous
Cyclo(His-Pro) min. 98 % (TLC) C3772 Metabolite
Somatostatins  
Somatostatin min. 97 % (HPLC) powder cell culture tested S1763 Endogenous
Somatostatin min. 97 % (HPLC) powder S9129 Endogenous
Somatostatin 28 min. 97 % (HPLC) S6135 Endogenous
Somatostatin Fragment 2-9 min. 97 % (HPLC) solid S9313 Nonselective
Somatostatin Fragment 3-10 min. 96 % (HPLC) solid S9438 Nonselective
Somatostatin Fragment 3-14 min. 95 % (HPLC) solid S9688 Nonselective
Somatostatin Fragment 7-14 min. 96 % (HPLC) solid S9563 Nonselective
b-(2-Naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr amide [Disulfide Bridge: 2-7] min. 97 % (HPLC) N9642 Prefers sstr2
Seglitide >98 % (HPLC) S1316 sstr2
[D-Trp8]-Somatostatin min. 97 % (HPLC) S2511  
Cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[Bzl]) min. 97 % (HPLC) C4801 Nonselective
Tachykinins  
Substance P acetate salt hydrate min. 98 % (HPLC) powder S6883 Endogenous, prefers NK1
Neurokinin A min. 97 % (HPLC) N4267 Endogenous, prefers NK2
Neurokinin B min. 95 % (HPLC) N4143 Endogenous, prefers NK3
Entero-hylambatin >97 % (HPLC) powder H4534 NK1
GR-73632 >97 % G-114 NK1
Hylambatin >96 % (HPLC) H0409 NK1
[Sar9]-Substance P min. 97 % (HPLC) S6636 NK1
[Sar9, Met(O2)11]-Substance P min. 97 % (HPLC) S3672 NK1
d-Aminovaleryl-[Pro9, Leu(N-Me)10]-Substance P Fragment 7-11 >99 % (HPLC) solid S2314 NK1
Acetyl-[Arg6, Sar9, Met(O2)11]-Substance P Fragment 6-11 approx. 98 % S2275 NK1
GR-64349 >96 % G-113 NK2
[b-Ala8]-Neurokinin A Fragment 4-10 min. 97 % (HPLC) powder N-147 NK2
[Ala5, b-Ala8]-a-Neurokinin Fragment 4-10 min. 97 % (HPLC) N6144 NK2
Eledoisin min. 97 % (HPLC) E7880 NK2, NK3
Succinyl-[Asp6, N-Me-Phe8]-Substance P Fragment 6-11 min. 97 % (HPLC) S6772 NK3
N-Acetyl-L-tryptophan 3,5-bis(trifluoromethyl)benzyl ester min. 99 % (TLC) powder A5330 NK1
GR-82334 >97 % G-115 NK1
L-703,606 oxalate salt solid L-119 NK1
L-733,060 hydrochloride solid L-137 NK1
L-733,061 hydrochloride solid L-138 Less active enantiomer of L-733,060
[D-Arg1, D-Phe5, D-Trp7,9, Leu11]-Substance P min. 97 % (HPLC) S3144 NK1
[D-Arg1, D-Trp7,9, Leu11]-Substance P acetate salt min. 97 % (HPLC) S0274 NK1
WIN 51,708 solid W-103 NK1
WIN 62,577 solid W-104 NK1
GR-159897 solid >97 % (HPLC) G7543 NK2
GR-94800 >96 % powder G-130 NK2
L-659,877 >95 % powder L-117 NK2
MEN-10,376 min. 95 % (HPLC) solid M-157 NK2
SB 222200 >98 % (HPLC) S5192 NK3
SB 218795 >98 % (HPLC) S8817 NK3
NK2 Tachykinin Receptor human recombinant, expressed in CHO cells Membrane suspension T-180  
Vasoactive Intestinal Peptides  
Vasoactive Intestinal Peptide from human, porcine, rat min. 95 % (HPLC) powder V3628 Endogenous
Vasoactive Intestinal Peptide from human, porcine, rat min. 95 % (HPLC) powder V6130 Endogenous
Helodermin >90 % (HPLC) Ethanol solution H4660 VPAC2
Vasoactive Intestinal Peptide Fragment 10-28 human, porcine, rat acetate salt min. 97 % (HPLC) V5380  
Vasoactive Intestinal Peptide Fragment 6-28 human, porcine, rat min. 97 % (HPLC) V4508  
[D-p-Cl-Phe6, Leu17]-Vasoactive Intestinal Peptide human, porcine, rat min. 97 % (HPLC) V4380  
[Lys1, Pro2,5, Arg3,4, Tyr6]-Vasoactive Intestinal Peptide human, porcine, rat min. 97 % (HPLC) V2132  
Vasopressin  
[Arg8]-Vasopressin Grade VI (synthetic) approx. 100 I.U./ml in 0.9% NaCl V0377 Endogenous
[Arg8]-Vasopressin acetate salt min. 98 % (HPLC) V9879 Endogenous
[Lys8]-Vasopressin min. 98 % (HPLC) V6879 Endogenous
[Arg8]-Vasotocin acetate salt min. 97 % (HPLC) V0130 Non-mammalian
[deamino-Cys1, D-3-Pyridyl-Ala2, Arg8]-Vasopressin min. 97 % (HPLC) V2257 V1b
[deamino-Cys1, D-Arg8]-Vasopressin min. 97 % (HPLC) V1005 V2
[deamino-Cys1, Val4, D-Arg8]-Vasopressin min. 95 % V2013 V2
[deamino-Pen1, O-Me-Tyr2, Arg8]-Vasopressin min. 97 % (HPLC) V1880 V1
[b-Mercapto-b,b-cyclopentamethylenepropionyl1, O-me-Tyr2, Arg8]-Vasopressin min. 97 % (HPLC) V2255 V1a
[des-Gly9-b-Mercapto-b,b-cyclopentamethylenepropionyl1,O-Et-Tyr2,Val4,Arg8] -Vasopressin min. 97 % (HPLC) V4503 V1a,V2
[b-Mercapto-b,b-cyclopentamethylenepropionyl1, O-Et-Tyr2, Val4, Arg8]-Vasopressin min. 97 % (HPLC) V4253 V1a,V2
[Adamantaneacetyl1, O-Et-D-Tyr2, Val4, Aminobutyryl6, Arg8,9]-Vasopressin min. 95 % (HPLC) V2381 V2
Pharmacologicals   back to top
Product Name Product #  Specificity
Anticonvulsants  
N-(4-Amino-2-chlorophenyl)phthalimide A9345  
5,5-Diphenylhydantoin approx. 99 % D4007  
5,5-Diphenylhydantoin sodium salt approx. 99 % D4505  
Dubinidine min. 97 % (TLC) solid D7814  
Ethosuximide E7138  
Felbamate F0778  
Foliosidine min. 96 % (TLC) solid F6426  
Gabapentin solid G-154  
Lamotrigine min. 98 % L3791  
Valproic acid sodium salt P4543  
Zonisamide sodium salt solid Z2001  
Antidepressants  
Amitriptyline hydrochloride min. 98 % (TLC) powder A8404  
Amoxapine A-129  
Bupropion hydrochloride solid B-102  
Chlorprothixene hydrochloride C1671  
Citalopram hydrobromide C7861  
Desipramine hydrochloride min. 98 % (TLC) powder D3900  
Doxepin hydrochloride approx. 85 % as E-isomer min. 98 % (GC) 15 % as Z-isomer powder D4526  
GYKI 52895 solid G-120  
Hyperforin 1 mg/ml in methanol min. 85 % H5160  
Imipramine hydrochloride min. 98 % (TLC) crystalline I7379  
LY-367,265 L2411  
Mianserin hydrochloride M2525  
Nortriptyline hydrochloride min. 98 % (TLC) powder N7261  
cis-Thiothixene T0780  
Tianeptine Sodium-Potassium salt solid T1692  
Trazodone hydrochloride >99 % (HPLC) powder T6154  
Trimipramine maleate salt >99 % (TLC) powder T3146  
Zimelidine dihydrochloride solid Z-101  
Benzodiazepines and anxiolytics  
Alprazolam A8800  
Benzodiazepine Receptor Lyophilized powder E-005  
Bretazenil >98 % (HPLC) solid B6434  
Carbamazepine powder C4024  
Carbamazepine–HBC complex Free flowing powder C-162  
b-Carboline-3-carboxylic acid N-methylamide E-006  
CB 34 >98 % (HPLC) C6862  
Chlordiazepoxide hydrochloride C2517  
4'-Chlorodiazepam C5174  
Clobazam C8414  
Clonazepam powder C1277  
Desmethyldiazepam D7282  
Diazepam D0899  
N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide D8555 Mitochondrial
Estazolam E3638  
Flumazenil >99 % (HPLC) solid F6300 Benzodiazepine antagonist
Flunitrazepam F9261  
Flurazepam dihydrochloride solid F-103  
Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys min. 95 % (HPLC) G9898  
L-655,708 L9787 a5 subunit
(±)-Lorazepam L1764  
N-Methyl-b-carboline-3-carboxamide:HBC complex Free flowing powder M-156  
Methyl b-carboline-3-carboxylate solid E-002  
Methyl 6,7-dimethoxy-4-ethyl-b-carboline-3-carboxylate solid E-007  
3-Methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine M2922  
Midazolam maleate salt M2419  
Nitrazepam N3889  
Oxazepam O5254  
PK 11195 C0424 Benzodiazepine antagonist
Ro 15-4513 solid R-109 Benzodiazepine partial antagonist
Triazolam T9772  
Zolpidem >96 % solid Z-103  
Zopiclone Z4900  
Cannabinoids  
Arachidonyl-2'-chloroethylamide min. 97 % A9719 CB1
Arachidonyl-2'-chloroethylamide min. 97 % A9719 CB1
Arachidonylcyclopropylamide min. 98 % A2345 CB1
R(+)-Methanandamide 5 mg/ml in anhydrous ethanol >96 % M-186 CB1
CP55940 >98 % (HPLC) C1112 CB1 and CB2
Mead acid ethanolamide 10 mg/ml in ethanol >98 % M2564 CB1 and CB2
Nabilone min. 99 % (HPLC) solid N3785 CB1 and CB2
Indomethacin morpholinylamide solid I-151 CB2
JWH-015 J4252 CB2
JWH-133 solid J2753 CB2
Arachidonylethanolamide approx. 98 % (TLC) oil A0580 Endogenous CB1
Palmitoylethanolamide P0359 Endogenous CB2
Virodhamine hydrochloride >90 % (GC) oil V2389 Endogenous CB2 full, CB1 partial
2-Arachidonyl glycerol Acetonitrile solution approx. 10 mg/ml A8973 Endogenous Ligand
N-Arachidonylglycine ³98 % (HPLC) Waxy solid A1977 Endogenous Ligand
Cannabinol C6888 Nonselective
HU-210 solid H7909 Nonselective
D8-Tetrahydrocannabinol solution Ethanol solution T2511 Nonselective
D9-Tetrahydrocannabinol solution min. 90 % (GC, HPLC) Ethanol solution T2386 Nonselective
(R)-(+)-WIN 55,212-2 mesylate salt solid W-102 Nonselective
S(–)-WIN 55,212-3 mesylate salt solid W-109 Less active enantiomer
Methyl linolenyl fluorophosphonate min. 98 % Methyl acetate solution M2814  
Methyl g-linolenyl fluorophosphonate min. 98 % Methyl acetate solution M2689  
AM 251 trifluoroacetate salt >98 % (HPLC) solid A6226 CB1
Methyl arachidonyl fluorophosphonate min. 98 % Methyl acetate solution M2939  
Arachidonyl trifluoromethyl ketone liquid A-231 Anandamide hydrolysis
CB2 Cannabinoid Receptor recombinant, expressed in CHO-K1 cells C-243  
AM404 5 mg/ml in anhydrous ethanol A-262 Anandamide
OMDM-1 min. 97 % (HPLC) powder O2389 Anandamide
VDM 11 ³98 % (HPLC) oil V3264 Anandamide
Ergot alkaloids  
2-Bromo-a-ergocryptine methanesulfonate salt solid B2134  
Dihydroergocristine methanesulfonate salt D-155  
Dihydroergotamine methanesulfonate salt powder D2763  
Ergocornine >95 % solid E-131  
Ergocristine E-140  
a-Ergocryptine E5625  
Ergoloid mesylate salt E2770  
Ergonovine powder E7008  
Ergonovine maleate salt E6500  
Lysergic acid diethylamide L7007  
Maleic acid 99 % M-153  
Metergoline M3668  
Methylergonovine maleate salt min. 98 % (TLC) M2776  
Methysergide maleate salt solid M-137  
6-Norlysergic acid diethylamide powder N5270  
Pergolide mesylate salt min. 98 % solid P8828  
Melatonins  
Melatonin powder M5250 Endogenous
N-Acetyl-5-hydroxytryptamine min. 99 % (TLC) powder A1824  
N-Acetyltryptamine powder A7342  
6-Chloromelatonin C0331  
6-Hydroxymelatonin H0627  
2-Iodomelatonin I1899  
IIK7 I5531  
GR 135531 solid >98 % (HPLC) G0294 MT3
K 185 K1888  
Luzindole min. 90 % L2407  
Nootropics  
Aniracetam approx. 98 % A9950  
Centrophenoxine hydrochloride C8773  
CR 2249 N2034  
DM 235 solid D5689  
Linopirdine solid L-134  
Oxiracetam O3011  
Piracetam P5295  
Opioids  
BW373U86 dihydrobromide powder B8930 γ
SNC80 solid S2812 γ
TAN-67 dihydrobromide ³98 % (HPLC) solid T5824 γ
b-Funaltrexamine hydrochloride solid O-003 κ
GR-89696 fumarate salt solid G-133 κ
Naloxone benzoylhydrazone solid N-165 κ
Salvinorin A crystal S2068 κ
(-)-trans-(1S,2S)-U-50488 hydrochloride solid U-111 κ
(±)-trans-U-50488 methanesulfonate salt D8040 κ
U-62066 solid U-105 κ
U-69593 solid U-103 κ
ICI 204,448 hydrochloride solid I-122 κ (peripheral)
BRL 52537 hydrochloride >98 % (HPLC) B5559 κ/µ
Codeine sulfate salt C-122 µ
Fentanyl citrate salt F3886 µ
Hydrocodone (+)-bitartrate salt H4516 µ
Hydromorphone hydrochloride H5136 µ
Levorphanol tartrate salt L5143 µ
Meperidine hydrochloride M3142 µ
(±)-Methadone hydrochloride M0267 µ
Morphine 6-b-D-glucuronide hydrate min. 90 % (HPLC) M3528 µ
Morphine sulfate salt pentahydrate M8777 µ > κ
Loperamide hydrochloride L4762 µ (peripheral)
Nalbuphine hydrochloride dihydrate min. 98 % (HPLC) N4396 µ partial agonist
Butorphanol tartrate salt min. 99 % B9156 "µ, κ"
L-687,384 hydrochloride min. 98 % L8539 σ1
PRE-084 solid P2607 σ1
S(+)-Methadone hydrochloride solid M-150 less potent enantiomer
(+)-trans-(1R,2R)-U-50488 hydrochloride solid U-110 less potent enantiomer
Buprenorphine hydrochloride B9275 ORL1
Orphanin FQ min. 95 % (HPLC) O4011 ORL1
ICI 174,864 solid I-128 γ
Naltrindole hydrochloride solid N-115 γ
Naltriben methanesulfonate salt solid N-156 γ2
Naltrindole isothiocyanate hydrochloride solid N-157 γ2
(S)-DIPPA hydrochloride solid D4939 κ
Guanidinyl-naltrindole solid G3416 κ
CTAP min. 95 % C6352 µ
Cyprodime hydrobromide >96 % solid C-153 µ
3-Methoxynaltrexone hydrochloride solid M-231 µ
b-Funaltrexamine hydrochloride solid O-003 µ alkylating agent
Naloxonazine dihydrochloride solid N-176 µ1
AC915 oxalate salt A3595 σ1
Buprenorphine hydrochloride B9275 Nonselective
Nalmefene N5770 Nonselective
Naloxone hydrochloride dihydrate min. 98 % (TLC and titration) powder N7758 Nonselective
Naltrexone hydrochloride N3136 Nonselective
9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride monohydrate 97 % "34,643-8" Nonselective
b-Chlornaltrexamine dihydrochloride solid O-001 Nonselective (irreversible)
Naloxone methiodide solid N-129 Nonselective (peripheral)
Levallorphan tartrate salt solid L-121 Nonselective partial agonist
Nalorphine hydrochloride solid N-100 Nonselective partial agonist
Morphine 3-b-D-glucuronide M6886 Morphine
Thebaine powder T2019 Morphine
Sedatives/Hypnotics  
2-Bromo-2-chloro-1,1,1-trifluoroethane min. 99 % B4388  
Chloral hydrate C8383  
Chloralose SigmaUltra min. 98 % C8091  
a-Chloralose-HBC complex ³92 % as a-Anomer C8849  
Ethinamate E3258  
Evoxine min. 98 % (TLC) solid E7652  
Inactin® solid T-133  
(±)-Ketamine hydrochloride solid K2753  
Ketamine hydrochloride/xylazine hydrochloride solution K-113  
Methaqualone hydrochloride M3637  
Paraldehyde P5520  
Pentobarbital sodium salt P3761  
Phenobarbital sodium salt P5178  
Secobarbital sodium salt S1378  
(±)-Thiopental sodium salt sodium carbonate mixture T6023  
Sigma receptor  
(+)-Cyclazocine solid C-147 σ
Perphenazine P6402 σ
Phencyclidine hydrochloride P3029 σ
(-)-cis-(1S,2R)-U-50488 tartrate solid U-106 σ
Metaphit methanesulfonate salt solid M-120 σ alkylating agent
(+)-N-Allylnormetazocine hydrochloride solid A-114 σ1
Carbetapentane citrate salt C4662 σ1
(+)-Pentazocine solid P-127 σ1
Haloperidol powder H1512 σ1 σ2
R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine hydrochloride solid P-102 σ1 mixed agonist/antagonist
Ibogaine hydrochloride I7003 σ2
Ifenprodil tartrate salt I2892 σ2
Stimulants  
D-Amphetamine sulfate salt A5880  
DL-Amphetamine sulfate salt A1263  
Benzphetamine hydrochloride B8263  
Cathine hydrochloride from khat shrub (Arabia, Ethiopia) solid C-222  
S(-)-Cathinone hydrochloride C3196  
Cocaine hydrochloride C5776  
Cocaine free base C8912  
R(-)-Fenfluramine hydrochloride F-113  
(+)-Fenfluramine hydrochloride F-112  
(±)-Fenfluramine hydrochloride F8507  
Harmaline H2256  
Harmaline hydrochloride dihydrate approx. 95 % H1392  
Harmane H7258  
Harmine H8646  
Harmine hydrochloride approx. 98 % H0625  
Ibogaine hydrochloride I7003  
(+)-Methamphetamine hydrochloride M8750  
(±)-p-Methoxyamphetamine hydrochloride M3404  
2-(Methylamino)propiophenone hydrochloride M5037  
(±)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine hydrochloride solid M-200  
D-threo-Methylphenidate hydrochloride solid M6810  
L-threo-Methylphenidate hydrochloride solid M6935  
Methylphenidate hydrochloride M2892  
Modafinil >98 % (HPLC) M6940  
DL-Norephedrine hydrochloride min. 99 % P7876  
Norharmane crystalline N6252  
Norharmane hydrochloride crystalline N6377  
Pentylenetetrazole P6500  
Phentermine hydrochloride P8653  
(+)-Pseudoephedrine hydrochloride E2750  
Vanillic acid diethylamide E0137  
Toxins  
L-BMAA hydrochloride >94 % solid B-107  
Botulinum Toxin A solution Clostridium botulinum B8776  
Botulinum Toxin B solution Clostridium botulinum B6403  
Cardiotoxin from Naja mossambica mossambica C9759  
Cardiotoxin from Naja naja kaouthia C1777  
a-Cobratoxin from Naja naja kaouthia C6903  
a-Latrotoxin powder L-127  
Philanthotoxin 343 tris(trifluoroacetate) salt solid P-206  
Philanthotoxin 433 tris(trifluoroacetate) salt >99 % solid P-207  
Vanilloids  
Arvanil min. 90 % liquid A2098 Agonist
Capsaicin min. 95 % from Capsicum M2028 Agonist
Icilin min. 98 % (HPLC) I9532 Agonist
Isovelleral solid I1279 Agonist
N-Oleoyldopamine O2139 Agonist
Olvanil powder O0257 Agonist
Phorbol 12,13-didecanoate 20-homovanillate min. 98 % P9983 Agonist
Phorbol 12,13-dinonanoate 20-homovanillate P0234 Agonist
Phorbol 12-phenylacetate 13-acetate 20-homovanillate solid P-266 Agonist
Resiniferatoxin from Euphorbia poisonii approx. 95 % R8756 Agonist
Scutigeral from Albatrellus ovinus (edible mushroom) min. 98 % S8186 Agonist
Capsazepine solid C-191 Antagonist
5'-Iodoresiniferatoxin solid I9281 Antagonist
SB-366791 >98 % (HPLC) S0441 Antagonist
Ruthenium Red R2751 Channel blocker
Serotonergics   back to top
Product Name Product #  Specificity
Agonists  
Serotonin creatinine sulfate complex powder H7752 Endogenous
Serotonin hydrochloride powder H9523 Endogenous
Serotonin hydrogen maleate powder H4511 Endogenous
Serotonin hydrogen oxalate crystalline H7877 Endogenous
Tryptamine min. 99 % crystalline T2891 Endogenous
Dihydroergocristine methanesulfonate salt D-155 5-HT1
Dihydroergotamine methanesulfonate salt powder D2763 5-HT1
R(+)-Lisuride hydrogen maleate solid L-118 5-HT1
1-(1-Naphthyl)piperazine hydrochloride needles S-003 5-HT1
Oxymetazoline hydrochloride solid O2378 5-HT1
Buspirone hydrochloride B7148 5-HT1A
N,N-Dipropyl-5-carboxamidotryptamine maleate salt solid D-132 5-HT1A
LY-165,163 solid S-009 5-HT1A
Rauwolscine hydrochloride solid R-104 5-HT1A
R(+)-UH-301 hydrochloride solid U-109 5-HT1A
WB-4101 hydrochloride >99 % (TLC) solid D0411 5-HT1A
(R)-(+)-8-Hydroxy-DPAT hydrobromide solid H-140 5-HT1A full agonist
BMY 7378 dihydrochloride >98 % solid B-134 5-HT1A partial agonist
S(-)-8-Hydroxy-DPAT hydrobromide solid H-141 5-HT1A partial agonist
CGS-12066A maleate salt solid C-106 5-HT1B
1-(a,a,a-Trifluoro-m-tolyl)piperazine 96 % T9073 5-HT1B
L-694,247 solid L-129 5-HT1B, 5-HT1D
GR 46611 >98 % (HPLC) G8543 5-HT1D
5-(Nonyloxy)tryptamine hydrogen oxalate solid N-178 5-HT1D
BRL 54443 maleate salt solid B-173 5-HT1E/1F
1-(3-Chlorophenyl)piperazine hydrochloride C5554 5-HT2
(±)-2,5-Dimethoxy-4-bromoamphetamine hydrobromide D7412 5-HT2
(R)(-)-DOI hydrochloride solid D-153 5-HT2
(±)-DOI hydrochloride solid D-101 5-HT2
a-Methylserotonin maleate salt solid M-110 5-HT2 > 5-HT1
(±)-1-(4-Bromo-2,5-dimethoxyphenyl)-2-ethanamine hydrochloride solid B-159 5-HT2, 5-HT1
BW 723C86 solid B-175 5-HT2B
VER-3323 hemifumarate salt >98 % (HPLC) V1889 5-HT2C, 5-HT2B
Trazodone hydrochloride >99 % (HPLC) powder T6154 5-HT2C
1-(3-Chlorophenyl)biguanide hydrochloride solid C-144 5-HT3
N-Methylquipazine dimaleate salt solid Q-107 5-HT3
2-Methylserotonin maleate salt solid M-109 5-HT3
Phenylbiguanide P-120 5-HT3
SR 57227A solid S1688 5-HT3
N,N,N-Trimethylserotonin iodide solid H-133 5-HT3
Oleamide min. 99 % O2136 5-HT7 allosteric
S(+)-DOI hydrochloride solid D-154 Less potent enantiomer
Amperozide hydrochloride min. 98 % (HPLC) A6976 Nonselective
5-Carboxamidotryptamine maleate salt solid C-117 Nonselective
Lysergic acid diethylamide L7007 Nonselective
5-Methoxy-N,N-dimethyltryptamine M2381 Nonselective
Psilocin P2279 Nonselective
Quipazine maleate salt Q1004 Nonselective
Antagonists  
Methysergide maleate salt solid M-137 5-HT1, 5-HT2, 5-HT7
Spiperone solid S7395 5-HT1, 5-HT2A
Methiothepin mesylate salt solid M-149 5-HT1, 5-HT6, 5-HT7
S(-)-Cyanopindolol hemifumarate salt solid C-238 5-HT1A/1B
p-MPPF dihydrochloride solid M-226 5-HT1A
p-MPPI hydrochloride solid M-204 5-HT1A
NAN-190 hydrobromide N3529 5-HT1A
Pindobind-5HT1A >89 % solid P-150 5-HT1A
Pindolol min. 98 % (TLC) powder P0778 5-HT1A
S(–)-Pindolol solid P-152 5-HT1A
Spiroxatrine powder S-103 5-HT1A
S(-)-UH-301 hydrochloride solid U-108 5-HT1A
WAY-100635 maleate salt solid W-108 5-HT1A
GR 127935 hydrochloride >98 % (HPLC) G5793 5-HT1B
SB-216641 ³99 % (HPLC) solid S8942 5-HT1B
SB-224289 hydrochloride solid S-201 5-HT1B
GR 55562 dihydrobromide >97 % (HPLC) powder G0419 5-HT1B/1D
BRL 15572 B9929 5-HT1D
LY-165,163 solid S-009 5-HT1D
LY-310,762 hydrochloride White powder L2536 5-HT1D
Amoxapine A-129 5-HT2
Cyclobenzaprine hydrochloride C4542 5-HT2
Cyproheptadine hydrochloride C6022 5-HT2
Ketanserin tartrate salt >97 % solid S-006 5-HT2
LY-53,857 maleate salt solid L-107 5-HT2
1-(1-Naphthyl)piperazine hydrochloride needles S-003 5-HT2
Nortriptyline hydrochloride min. 98 % (TLC) powder N7261 5-HT2
Octoclothepin maleate salt solid O-111 5-HT2
Pirenperone >97 % solid P-126 5-HT2
Risperidone solid R-118 5-HT2
SB-204741 >98 % (HPLC) S0693 5-HT2
Mianserin hydrochloride M2525 5-HT2, 5-HT3
Ritanserin solid R-103 5-HT2, 5-HT7
LY-367,265 L2411 5-HT2A
Loxapine succinate salt solid L-106 5-HT2A, 5-HT2B, 5-HT7
SB-215505 solid >98 % (HPLC) S1068 5-HT2B
SB-206553 hydrochloride solid S-180 5-HT2B, 5-HT2C
SB-221284 solid >98 % (HPLC) S2193 5-HT2B, 5-HT2C
SB 228357 ³99 % (HPLC) solid S2318 5-HT2B, 5-HT2C
SB-200646 hydrochloride >98 % (HPLC) S0568 5-HT2C, 5-HT2B
Maleic acid 99 % M-153 5-HT2C
SB 242084 dihydrochloride min. 99 % S8061 5-HT2C
LY-278,584 maleate salt solid L-110 5-HT3
Metoclopramide hydrochloride solid M0763 5-HT3
3-Tropanylindole-3-carboxylate hydrochoride solid T-104 5-HT3
3-Tropanylindole-3-carboxylate methiodide solid T-113 5-HT3
GR 113808 >98 % (HPLC) G5918 5-HT4
GR 125487 sulfamate salt >98 % (HPLC) G6043 5-HT4
SB-203186 99 % (HPLC) S0443 5-HT4
SB-204070 hydrochloride solid >98 % (HPLC) S3313 5-HT4
SDZ-205,557 hydrochloride solid S-174 5-HT4
Ro 04-6790 dihydrochloride solid R-140 5-HT6
R(+)-Lisuride hydrogen maleate solid L-118 5-HT7
Pimozide P1793 5-HT7
SB-269970 hydrochloride solid S7389 5-HT7
Clozapine C6305 Nonselective
Metergoline M3668 Nonselective
Enzyme inhibitors  
Benserazide hydrochloride min. 98 % (TLC) solid B7283 L-Amino acid decarboxylase
S(-)-Carbidopa: HBC complex C-164 L-Amino acid decarboxylase
(±)-3-(3,4-Dihydroxyphenyl)-2-methyl-DL-alanine M7277 L-Amino acid decarboxylase
3-Hydroxybenzylhydrazine dihydrochloride 95-98 % (TLC) H9382 L-Amino acid decarboxylase
R-(-)-Deprenyl hydrochloride solid M-003 Monoamine oxidase
R-(–)-Desmethyldeprenyl hydrochloride >98 % (HPLC) D6940 Monoamine oxidase
Hydralazine hydrochloride H1753 Monoamine oxidase
Hydroxylamine hydrochloride min. 99 % (titration) H9876 Monoamine oxidase
Hydroxylamine sulfate salt min. 99 % (titration) H0127 Monoamine oxidase
Iproniazid phosphate salt I7627 Monoamine oxidase
N-Methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine hydrochloride M3778 Monoamine oxidase
Nialamide min. 95 % (HPLC) N1392 Monoamine oxidase
Pargyline hydrochloride P8013 Monoamine oxidase
Phenelzine sulfate salt P6777 Monoamine oxidase
trans-2-Phenylcyclopropylamine hemisulfate salt P1761 Monoamine oxidase
trans-2-Phenylcyclopropylamine hydrochloride P8511 Monoamine oxidase
Quinacrine dihydrochloride min. 90 % Q3251 Monoamine oxidase
Ro 41-1049 hydrochloride solid R-107 Monoamine oxidase
Ro 16-6491 hydrochloride solid R-106 Monoamine oxidase
4-Chloro-L-phenylalanine C8655 Tryptophan hydroxylase
4-Chloro-DL-phenylalanine C6506 Tryptophan hydroxylase
4-Chloro-DL-phenylalanine methyl ester hydrochloride C3635 Tryptophan hydroxylase
Metabolites  
5-Hydroxyindole-3-acetic acid min. 98 % (titration) crystalline H8876  
5-Hydroxyindole-3-acetic acid (dicyclohexylammonium) salt Sigma Grade 99-100 % (GC) crystalline H2255  
5-Hydroxytryptophol approx. 98 % H1880  
Nw-Methyl-5-hydroxy­trypt­amine oxalate salt ³98 % (alkalimetric) M1514  
Neurotoxins  
DL-p-Chloroamphetamine hydrochloride 95-98 % C9635  
1-Methyl-4-(2-aminophenyl)-1,2,3,6-tetrahydropyridine min. 95 % (HPLC) A7969  
(±)-3,4-Methylenedioxyamphetamine hydrochloride min. 98 % (TLC) M6267  
(±)-3,4-Methylenedioxy-N-­ethyl­amphetamine hydrochloride min. 98 % (TLC) M1796  
(±)-3,4-Methylenedioxymethamphetamine hydrochloride M6403  
S(+)-3,4-Methylenedioxymethamphetamine hydrochloride solid M-139  
Precursors
5-Hydroxy-L-tryptophan solid H9772  
5-Hydroxy-DL-tryptophan Sigma Grade approx. 99 % H8127  
L-Tryptophan min. 98 % (TLC) T0254  
Receptors
5-HT7 Serotonin Receptor from rat recombinant, expressed in Sf 9 cells S-162  
5-HT7 Serotonin Receptor from rat recombinant, expressed in HEK-293 S-170  
5-HT7 Serotonin Receptor human recombinant, expressed in CHO cells Membrane suspension S-177  
5-HT1A Serotonin Receptor human recombinant, expressed in Sf 9 cells Membrane suspension S-160  
Releasers  
R(-)-Fenfluramine hydrochloride F-113 Less active enantiomer
DL-p-Chloroamphetamine hydrochloride 95-98 % C9635  
(+)-Fenfluramine hydrochloride F-112  
(±)-Fenfluramine hydrochloride F8507  
(±)-p-Methoxyamphetamine hydrochloride M3404  
Transporter  
Serotonin Transporter Receptor Membrane suspension S1943  
Transport inhibitors  
Alaproclate hydrochloride A-164  
(-)-2b-Carbomethoxy-3b-(4-iodophenyl)nortropane crystalline C-155  
Clomipramine hydrochloride min. 98 % (HPLC) powder C7291  
Fluoxetine hydrochloride solid F-132  
6-Nitroquipazine maleate salt solid Q-109  
Norfluoxetine hydrochloride >97 % solid F-133  
Zimelidine dihydrochloride solid Z-101  
Reserpine R0875 Vesicular transport inhibitors

back to top
your favorite gene search

powered by ingenuity

Service & Support
Ordering
Corporate

©2011 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA, SAFC, SIGMA-ALDRICH, ALDRICH, and SUPELCO are trademarks of Sigma-Aldrich Co. LLC, registered in the US and other countries. FLUKA is a trademark of Sigma-Aldrich GmbH, registered in the US and other countries. Sigma brand products are sold through Sigma-Aldrich, Inc. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Site Use Terms | Privacy

  • YouTube
  • Twitter
  • LinkedIN
  • Facebook